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 Familial Amyloid Polyneuropathy (FAP) is a neurodegenerative disease 
characterized by the deposition of mutated transthyretin (TTR) in the form amyloid fibrils, 
particularly in the peripheral nervous system. The most common pathogenic substitution is 
Val30Met and as a consequence of TTR deposition there is axonal degeneration that 
results in neuronal death with disease progression. Although therapeutic strategies have 
been implemented, none targets neurodegeneration, which remains irreversible, 
suggesting that further characterization of cellular pathways and identification of new drug 
targets involved in FAP are required. 
Preliminary in vitro data from our laboratory suggested that cytoskeleton defects are 
involved in FAP pathogenesis. Aiming at determining whether cytoskeleton remodelling is 
a target for TTR-induced neurodegeneration in vivo we used a previously reported 
Drosophila model for FAP. The fly model for FAP is based on the expression of human 
TTRV30M in differentiated cells of the fly developing eye (photoreceptor cells and 
accessory cells). Expression of TTR transgenes led to roughening of the eye and 
degeneration, when compared with wild-type flies. We also detected reduced lifespan and 
impairment of climbing ability in TTR expressing flies. The effect of TTR in the parameters 
described above is gene dosage and temperature dependent, and appears consistently 
more severe in TTRV30M expressing flies.  
In order to determine whether a defect in axonal cytoskeleton precedes 
neurodegeneration, we evaluated the cytoskeleton organization of photoreceptor cells 
using different markers, as Chaoptin, a photoreceptor cell-specific membrane 
glycoprotein, Futsch, a microtubule associated protein and Lifeact, a construct that labels 
F-actin. The evaluation was performed in larval stage and we found defects in target and 
organization of the photoreceptor projecting axons. Moreover, we detected an abnormal 
distribution of F-actin in the growth cones of photoreceptor cells. The defects found were 
always more severe in larvae expressing TTRV30M when compared to WT TTR 
expression. The evaluation of glial cells proposed that they are not affected upon 
expression of TTR transgenes. 
In addition, we performed a genetic screen to identify enhancers and suppressors of 
TTRV30M-induced rough eye phenotype. Flies expressing TTRV30M were crossed with 
RNAi fly lines for candidate genes whose functions are associated with cytoskeleton 
dynamics. We found mainly suppressors of the phenotype promoted by TTRV30M 
expression and one enhancer. The results of the screen suggest a major involvement of 
the cytoskeleton regulators in the TTRV30M-induced phenotype, with a particular role of 
Rho GTPases proteins in the modulation of the phenotype. 
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In summary, this work highlighted that cytoskeleton defects underlie TTR-induced 
neurodegeneration and pinpointed novel TTR interactors. 
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A Polineuropatia Amiloidótica Familiar (PAF) é uma doença neurodegenerativa 
caracterizada pela deposição da proteína transtirretina (TTR) mutada, na forma de fibras 
de amilóide, particularmente no sistema nervoso periférico (SNP). A mutação patogénica 
mais comum é a substituição Val30Met e como consequência da deposição de TTR 
existe degeneração axonal que resulta em morte neuronal com a progressão da doença. 
Embora já tenham sido implementadas estratégias terapêuticas, nenhuma tem como alvo 
a neurodegeneração, que se mantem irreversível. Isto sugere que é necessária uma 
melhor caracterização das vias celulares envolvidas na doença e identificação de novos 
alvos terapêuticos para a PAF. 
Resultados preliminares obtidos in vitro no nosso laboratório sugeriram que 
defeitos no citosqueleto estão envolvidos na patogénese da PAF. De forma a determinar 
se a remodelação do citosqueleto é alvo da neurodegeneração induzida pela TTR in vivo, 
usamos um modelo de PAF previamente descrito em Drosophila. Este modelo baseou-se 
na expressão de TTR humana em células diferenciadas (fotorecetores) durante o 
desenvolvimento do olho da mosca. A expressão de TTR humana na mosca resultou em 
rugosidade do olho e degeneração, quando comparado com moscas do tipo selvagem. 
Também detetamos uma redução da longevidade e disfunção da capacidade motora em 
ensaios de climbing nas moscas que expressam TTR. O efeito da TTR nestes 
parâmetros é dependente do número de cópias do gene e da temperatura, sendo sempre 
mais severo em moscas que expressam  TTRV30M. 
De modo a determinar se um defeito no citosqueleto axonal precede a 
neurodegeneração avaliamos a organização das células fotorecetoras usando diferentes 
marcadores como Chaoptin, uma glicoproteína membranar especifica das células 
fotorecetoras; Futsch, uma proteína associada a microtúbulos; e Lifeact, um constructo 
que marca especificamente filamentos de actina. A avaliação foi efetuada na fase larvar e 
foram encontrados defeitos no direcionamento e organização dos axónios dos 
fotorecetores. Para além disso, detetamos também uma distribuição anormal dos 
filamentos de actina nos cones de crescimento das células fotorecetoras. Estes defeitos 
apresentaram-se sempre mais severos nas larvas que expressam TTRV30M, quando 
comparadas com a expressão de TTR selvagem. A avaliação das células gliais propôs 
que estas não são afetadas após expressão dos transgenes de TTR. 
Adicionalmente, efetuou-se um rastreio genético para identificar potenciadores e 
supressores do fenótipo do olho rugoso induzido pela TTRV30M. Moscas que expressam 
TTRV30M foram cruzadas com linhas de moscas RNAi para genes candidatos cujas 
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funções estão associadas à dinâmica do citoesqueleto. Encontramos maioritariamente 
supressores do fenótipo promovido pela expressão de TTR e apenas um potenciador. Os 
resultados do rastreio sugerem um maior envolvimento dos reguladores do citoesqueleto 
no fenótipo induzido pela TTR, com particular envolvimento das proteínas Rho GTPases 
na modelação do fenótipo. 
Este trabalho realça que defeitos do citoesqueleto poderão ser responsáveis pela 
neurodegeneração induzida pela TTR e identificou novos interatores da TTR.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Palavras-Chave: Polineuropatia amiloidótica familiar, transtirretina, citoesqueleto, 
Drosophila.
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 1 FAMILIAL AMYLOID POLYNEUROPATHY 
 
Familial amyloid polyneuropathy (FAP) is an autosomal dominant disease 
characterized by peripheral neuropathy initially described in the north of Portugal in 1952 
by the prestigious neurologist Corino de Andrade (Andrade, 1952). The major symptoms 
reported were the lost of pain and temperature sensation (Andrade, 1952). Posteriorly, 
FAP was identified in Japan (Araki et al., 1968) and Sweden (Andersson, 1976). In 1978 
Costa and colleagues identified transthyretin (TTR) as the protein involved in the 
development of the disease (Costa et al., 1978). 
 
1.1 Transthyretin Biology 
 
TTR is a homotetrameric protein whose discovery dates back to 1942 when Kabat 
and colleagues described its presence in the human cerebrospinal fluid (CSF) (Kabat et 
al., 1942). The ttr gene is located in the long arm of chromosome 18, has approximately 7 
kb in length and contains 4 exons and 3 introns (Sasaki et al., 1985; Whitehead et al., 
1984). The first exon encodes a signal peptide that is cleaved upon secretion of mature 
TTR (Schreiber and Richardson, 1997). TTR protein is released to the plasma as a 
tetramer of identical subunits, each one composed by 127 aminoacids with a molecular 
mass of ~14 kDa (Kanda et al., 1974). As revealed by the X-ray crystal structure each 
TTR monomer is composed by eight β-strands arranged in two β-sheets and a short α-
helix between two of the β-strands (Figure 1) (Blake et al., 1978; Blake et al., 1974). The 
two dimers within the tetramer assemble forming a channel that is present throughout the 
protein creating two symmetrical binding sites (Figure 1) (Blake et al., 1978). 
Figure 1 – Structure of TTR tetramer. PDB entry 1TTA.  β-
sheets are depicted in shades of green, red and blue. The α-
helixes are represented in yellow and blue. 
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TTR is essentially synthesized in the liver, which provides the major pool of the 
protein in the plasma (Felding and Fex, 1982; Raz and Goodman, 1969), and in the 
choroid plexus of the brain, that contributes to the presence of TTR in the cerebrospinal 
fluid (CSF) (Dickson et al., 1985; Dickson and Schreiber, 1986). TTR is also synthesized 
in the retinal pigment epithelium (RPE), which function as blood barrier for the retina 
(Pfeffer et al., 2004). In the eye TTR and retinol binding protein (RBP) are synthesized in 
RPE cells and secreted together from the interphotoreceptor matrix, located at the apical 
side of these cells (Cavallaro et al., 1990). There are some suggestions indicating that 
TTR function as a carrier of thyroxine hormones (T4) during eye development (Ong et al., 
1994). Expression of TTR in other tissues such as the visceral yolk sac (Soprano et al., 
1986), placenta (McKinnon et al., 2005), intestine (Loughna et al., 1995), pancreas (Kato 
et al., 1985), heart, skeletal muscle and spleen (Soprano et al., 1985) has also been 
suggested. A single observation reported expression of TTR in the meninges (Blay et al., 
1993). Recently it was proposed the expression of TTR in Schwann cells of peripheral 
nerves in mice (Murakami et al., 2010). TTR is degraded majorly in the liver, muscle and 
skin, and in minor amounts in the kidney, adipose tissue, testis and gastrointestinal tract 
(Makover et al., 1988). TTR internalization in the liver is mediated by a yet unidentified 
receptor-associated protein (RAP)-sensitive receptor (Sousa and Saraiva, 2001) and in 
the kidney it was reported that the uptake of TTR is performed by the megalin receptor 
(Sousa et al., 2000b). A schematic overview of TTR metabolism is represented in Figure 
2. 
Regarding the expression of TTR, eutherians are the group of vertebrates most 
studied, including rodents and humans, and the tissues known to synthesize TTR include 
the ones referred above in which TTR is expressed throughout life. TTR has been 
identified in all classes of vertebrates including fish where some species express TTR 
Figure	  2	  –	  Schematic	  representation	  of	  TTR	  metabolism.	  TTR	  (red	  circles)	  is	  synthesised	  in	  the	  choroid	  plexus	  and	  liver	  
(a)	   and	   circulates	   in	   the	  plasma	   carrying	   RBP	   (green	   circle)	   and	  T4	   (yellow	   square)	   (b).	   TTR	   is	   uptaken	   by	   the	   liver,	  
through	  RAP-­‐sensitive	  uptake,	  and	  by	  the	  kidney	  through	  megalin	  (c).	  (Adapted	  from	  Saraiva,	  2002)	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during development (S. aurata) while in others it was detected the presence of TTR in 
adult tissues (Santos and Power, 1999). In the amphibian species studied, it was reported 
the expression of TTR in the liver during development (Prapunpoj et al., 2000). In some 
species of reptiles (eg. S. punctatus) it was detected the expression of TTR by the liver 
during development (Richardson et al., 2005) and in the choroid plexus of other species 
(eg. T. rugosa) (Achen et al., 1993) and in the eye (C. porosus) (Prapunpoj et al., 2002). 
The synthesis of TTR by the liver and choroid plexus was detected in several species of 
birds during development and in adult stage (Southwell et al., 1991). In polyprotodont 
marsupials TTR is synthesized in the liver during development (Richardson et al., 2005), 
while marsupials synthesize TTR in choroid plexus throughout life and diprotodont 
marsupials express TTR in the liver and choroid plexus in all ages (Richardson et al., 
1994). In non-vertebrates, proteins with an aminoacid sequence similar to human TTR 
have been described and named TTR-like proteins. The TTR-like protein genes were 
identified in bacteria (E. coli), in invertebrates (C. elegans) and in plants (A. thaliana). 
Similarly to TTR, these homologue proteins present a tetrameric structure although they 
present different localizations and functions, as they do not bind hormones or similar 
ligands (Hennebry et al., 2006). 
The name TransThyRetin derived from its first identified physiological function as 
Transporter of Thyroxine (T4) (Woeber and Ingbar, 1968) and Retinol, trough association 
with RBP (Goodman, 1987). TTR knockout (KO) mice exhibited diminished circulating 
levels of both ligands (Episkopou et al., 1993), however the levels of T4 in tissues were 
unaltered indicating that the animals are euthyroid, and the mice did not develop defects 
in retinol secretion and symptoms of vitamin A deficiency (van Bennekum et al., 2001). 
These data suggest that TTR is not fundamental to thyroid hormone and RBP-retinol 
metabolism (Palha et al., 1994; van Bennekum et al., 2001). 
Additional ligands were suggested to interact physiologically with TTR, such as 
norepinephrine (NE) oxidation products and yellow compounds (lutein and pterin), but the 
nature of these interactions is largely unknown (Liz et al., 2010). Other described TTR 
ligand is apolipoprotein A-I (apoA-I). It was demonstrated that about 1-2% of plasma TTR 
circulates in high density lipoprotein in association with ApoA-I (Sousa et al., 2000a). 
Posterior research about the nature of this interaction revealed that TTR is able to cleave 
ApoA-I proposing that TTR is a protease (Liz et al., 2004). The catalytic machinery of TTR 
was then characterized revealing that the protein is a metalloprotease (Liz et al., 2012). 
Additional TTR substrates were described namely amyloid β peptide (Aβ) (Costa et al., 
2008). In vitro studies showed that TTR is able to cleave both soluble and aggregated 
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forms of Aβ, suggesting that TTR proteolysis might be relevant in Alzheimer’s disease 
(AD) context (Costa et al., 2008). 
The involvement of TTR in a peripheral neuropathy prompted an intensive research 
concerning the role of TTR in nerve physiology. The biological functions of TTR in the 
nervous system were addressed using a TTR KO mouse model (Fleming et al., 2007). 
TTR KO mice were shown to present a sensorimotor impairment, and after sciatic nerve 
injury a decreased regenerative capacity, which was rescued by the local neuronal 
expression of TTR (Fleming et al., 2007). TTR involvement in nerve regeneration was 
shown to be related with the TTR ability to increase neurite outgrowth, and with an impact 
on axonal transport, as TTR KO mice present decreased retrograde transport (Fleming et 
al., 2009). Moreover, TTR neuritogenic activity was shown to be mediated by megalin-
dependent internalization (Fleming et al., 2009) and to be dependent of TTR proteolytic 
activity (Liz et al., 2009). 
 
1.2 Transthyretin amyloidosis 
 
As described above, TTR is a multifaceted protein with several physiological 
functions that has been strongly studied because its association with disease. Due to the 
enrichment of β-strands in TTR, this protein presents an elevated amyloidogenic potential. 
One of the consequences of wild-type (WT) TTR deposition is Senile Systemic 
Amyloidosis (SSA) characterized by cardiomyopathy in late stages of life (Sekijima et al., 
2011; Westermark et al., 1990). Moreover, some SSA patients were shown to develop 
polyneuropathy derived from WT TTR deposition (Lam et al., 2015). Several mutations 
have been described in TTR, being the pathogenic substitutions neuropathy-causing 
(Eneqvist and Sauer-Eriksson, 2001; Plante-Bordeneuve and Kerschen, 2013; Saraiva, 
2001). The deposition of mutated TTR also occurs in the eye in patients with FAP. The 
source of the protein deposited in the eye might be the RPE cells as the equilibrium 
between systemic circulation and vitreous humour is very slow (Planté-Bordeneuve and 
Said, 2011; Sandgren, 1995). The most common mutation described in FAP is a 
substitution of a valine for a methionine at the position 30 (V30M) (Saraiva et al., 1983). 
TTR with a substitution of a leucine for a proline at position 55 (L55P) originates a protein 
with a high amyloidogenic potential (Jacobson et al., 1992). The amyloidogenic mutations 
favour the destabilization of the TTR structure inducing the transition from the tetrameric 
structure to the monomeric one, which subsequently unfolds and aggregates leading to 
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the formation of soluble oligomers that evolve to insoluble amyloid fibrils (Figure 3) 
(Quintas et al., 2001). Other mutations in TTR have been described as protective 
(Arg104His or Thr119Met), as they stabilize the tetrameric structure of TTR contributing to 
a delayed course of the disease in patients carrying V30M substitution (Almeida et al., 
2000). 
 
1.3 Pathophysiology of FAP 
 
FAP is a fatal disease transmitted as an autosomal dominant trait, characterized by 
the deposition of mutated TTR in the form of amyloid fibrils in the peripheral nerves in the 
endoneurium or in contact with Schwann cells (Sousa et al., 2001a). Despite being the 
mutated TTR to trigger the deposition, genetic analysis revealed that the majority of the 
amyloid deposits found in heterozygous patients of FAP are constituted by a combination 
of both WT and mutated TTR (Mita et al., 1986; Tsuchiya-Suzuki et al., 2011). The 
neurological defects induced by TTR amyloid are initially detected in the unmyelinated 
and small myelinated fibres and then progress to the large calibre fibres. In the course of 
the disease axonal degeneration occurs in a length-dependent manner (dying-back) 
(Andrade, 1952; Said et al., 1984), with the nerves of the lower limbs being firstly affected 
and the upper limbs disturbed with progression of the neuropathy. The onset of the 
disease varies considerably but in Portuguese patients the first symptoms occur in the mid 
thirties with a progressive polyneuropathy in about 10-20 years which leads ultimately to 
death (Coutinho, 1980). 
Figure 3 – TTR amyloidogenic pathway. TTR tetramer is dissociated into monomers that upon partially 
denaturation start to assemble into aggregates including oligomers and amyloid fibrils. (Adapted from 
Johnson et al., 2012) 
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It was reported that different stages of fibrillogenesis present different levels of 
toxicity with the initial aggregated nonfibrillary forms of TTR being more toxic than the 
mature fibrils, suggesting neuronal stress at early stages of the disease (Sousa et al., 
2001a). Several hypothesis about the mechanisms by which TTR aggregates trigger 
neurodegeneration have been raised (Figure 4): i) the interaction of TTR with the Fas 
receptor leading to caspase activation and consequently apoptosis (Macedo et al., 2007); 
ii) disruption of the cellular membrane creating endoplasmic reticulum (ER) stress which 
induces the release of calcium stores and activation of caspase cascade (Saraiva et al., 
2012); iii) oxidative stress leading to mitochondria dysfunction and iv) interaction with the 
receptor for advanced glycation end products (RAGE) inducing NF-kB activation that 
consequently activates the transcription of inflammatory cytokines and oxidative stress 
molecules (Sousa et al., 2001b). The oxidized products might, in turn, be enhancers of the 
fibril formation. Signalling via NF-kB could be also responsible for the disruption of the 
extracellular matrix (ECM) affecting the amyloid formation.  
Figure 4 – Pathways for TTR-induced cellular toxicity in FAP. (1) Activation of the Fas receptor. (2) 
Disruption of cell membrane activating ER stress. (3) Interaction of TTR aggregates with RAGE. (4) 
Interaction of TTR with unknown receptors. The black arrows represent activation or expression and red 
dashed lines represent possible actions. (Adapted from Saraiva et al., 2012) 
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1.4 Therapeutic approaches 
 
The major therapeutic approach for FAP is liver transplantation, which targets the 
removal of the disease-causing protein. Liver transplantation was performed for the first 
time in 1990 and is a method frequently applied worldwide with more than 100 liver 
transplantations performed every year (Holmgren et al., 1991; Ueda and Ando, 2014). 
Transplanted patients present a drastically decline of mutant TTR in the serum (Holmgren 
et al., 1991) and the average of survival is increased in about 20 years (Okamoto et al., 
2009). Regarding the neuropathy, a large stabilization of the disease is observed, with 
greatest results when the liver transplantation is performed in the early stages of the 
disease (Adams et al., 2000). However, there are several criteria to be respected before 
transplantation and thus not all patients are able to receive a liver transplantation. Besides 
that, some contraindications have been reported after liver transplantation such as severe 
autonomic dysfunction, poor nutritional status, and cardiac amyloidosis, among others. 
This might be the result of continued accumulation of WT TTR in the pre-formed deposits, 
or deposition of the mutant TTR from other sources (Plante-Bordeneuve and Kerschen, 
2013).  
Besides liver transplantation, other therapeutic strategies have been developed to 
prevent the expression of the mutant protein. One of the methodologies is gene therapy in 
which two major approaches are used to silence the gene: the antisense oligonucleotide 
(ASO) and small interfering RNAs (siRNAs) that promote the enzymatic degradation of 
mRNA and sequence specific post-transcriptional gene silencing, respectively (Askari and 
McDonnell, 1996; Gilmore et al., 2006). The first studies showed that siRNA is able to 
silence selectively the mutated TTR gene expression (Kurosawa et al., 2005). Posteriorly, 
as the deposition of WT TTR also contributes to the amyloid formation in FAP, it was 
developed siRNA and ASO therapies able to inhibit the deposition of both mutant and WT 
TTR (Ackermann et al., 2012; Coelho et al., 2013). This is advantageous when comparing 
with liver transplantation because it simultaneously prevents the expression of TTR in 
choroid plexus and the accumulation of WT TTR, that still occurs in some cases after liver 
transplantation (Benson et al., 2010). 
Additionally, the development of TTR stabilizers emerged as a possible approach to 
inhibit formation of amyloid fibrils. Molecularly, these compounds are chaperones that 
specifically bind to TTR tetramers increasing their stability. The research for stabilizers 
raised two compounds, named tafamidis and diflusinal that specifically bind to the T4 site 
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(Berk et al., 2013; Coelho et al., 2012). Both entered in phase III clinical trials with 
tafamidis being approved by the European Commission for the treatment of FAP patients 
with early symptoms of neuropathy. Patients treated with this drug showed slower 
deterioration of the peripheral nerves and better quality of life without signs of significant 
side effects (Coelho et al., 2012). Tafamidis is the most promising treatment, discovered 
recently, with hopeful results, however, since these drugs do not reverse the already 
formed deposits, it is imperial an early diagnosis. 
The administration of molecules that promote the disruption of amyloid fibrils (Jono 
et al., 2011) and immunotherapy (Terazaki et al., 2006) have also been proposed. Until 
the evidence that the alternative approaches are safe, efficient and effective, liver 
transplantation is predominantly the choice to treat FAP patients. Nevertheless, new 
studies are needed in FAP therapeutics, what is mainly related to the fact that the 
available treatments do not include symptomatic and late-onset patients. Moreover, none 
of these approaches targets neurodegeneration that remains irreversible. 
 
1.5 FAP models  
 
There has been an effort to generate successful models for FAP. Several attempts 
have arisen and two research groups produced transgenic mice expressing human 
TTRV30M. Both achieved the formation of amyloid that presented similar features with 
that observed in FAP patients, with the deposition being observed in the gastrointestinal 
tract, cardiovascular system and kidneys. However, deposition was not observed in the 
peripheral nerves (Araki et al., 1994; Yi et al., 1991). A subsequent attempt resulted in the 
development of a mouse model producing the mutant TTRV30M and lacking the 
endogenous TTR. The same pattern of deposition was achieved leading to the conclusion 
that the mouse TTR has no influence in human TTRV30M deposition (Kohno et al., 1997). 
Another approach was to generate models expressing the highly amyloidogenic mutant 
TTRL55P. Besides the fibrillar deposition in the gastrointestinal track and skin, no 
deposits were detected in peripheral and autonomic nervous system (Sousa et al., 2002; 
Teng, 1996). Years later, a mouse model carrying the human TTRV30M in a heat shock 
transcription factor 1 (HSF1) KO background was generated. This model presented early 
and extensive TTR deposition in the peripheral and autonomic nerves. At 24 months of 
age, fibrillar material was detected in the sciatic nerve by electron microscopy 
accompanied by a significant decrease in the number of unmyelinated fibers (Santos et 
al., 2010). Although this model has developed essential features of the disease, the slow 
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progression of the disease constitutes a drawback to study the neurobiology of FAP. 
Besides mouse models, Drosophila FAP models were already established and will 
be dissected in the section 3.5. 
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 2 CYTOSKELETON AND NEURODEGENERATION 
 
A strong link between cytoskeleton alterations and neurodegeneration has emerged 
in the last years in several nervous system diseases. Concerning amyloid-induced 
neurodegenerative disorders, cytoskeleton defects have been mainly observed in AD, a 
disorder associated with progressive cognitive decline, characterized by the extracellular 
deposits of Aβ peptides and accumulation of hyperphosphorylated tau protein in 
neurofibrillary tangles (NFTs) in the central nervous system, particularly in the 
hippocampus and cortex (Blennow et al., 2006). Regarding peripheral neuropathies, 
cytoskeleton damage has been described in Charcot-Marie-Tooth disease (CMT), the 
most common inherited disorder of the peripheral nervous system (PNS), with 40 
causative genes having been associated with the disease (Pareyson and Marchesi, 
2009). Although FAP is a dying-back polyneuropathy, highlighting a potential link with 
cytoskeleton disruption, this hypothesis was not previously addressed. 
The integrity of the neuronal cytoskeleton depends on a critical regulation of its 
components: actin filaments, microtubules (MTs) and intermediate filaments (IFs).  
 
2.1 The neuronal cytoskeleton 
 
The neuronal structure is mainly composed by the cell body, from which arise several 
extensions called dendrites, and a long and thicker process, the axon. Neurons are the 
longest cells in animals, being the axon the main contributor for the size of these cells 
(Neukirchen and Bradke, 2011). Regarding the particular structure of this cell type, it is 
fundamental the precise assembly and control of the cytoskeleton components to maintain 
its integrity. 
The actin filaments (F-actin) are formed by the association of globular actin (G-actin) 
to a growing polymer (Mitchison and Cramer, 1996). F-actin is a filament polarized with 
different rates of monomer assembly and disassembly with the barbed end being of fast 
growing and the minus end of slower growing. There is a considerable number of actin 
binding proteins (ABPs) that regulate the dynamics of the actin filaments: i) nucleation 
factors (formins and Arp2/3) that promote the assembly of G-actin into filaments and the 
development of branched networks (Bugyi et al., 2006; Korobova and Svitkina, 2008); ii) 
polymerization proteins (profilin) that provide new subunits to the barbed end enhancing 
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the assembly of G-actin into F-actin (Mockrin and Korn, 1980); iii) proteins that bundle 
(fascin) or crosslink (α-actinins and filamins) the actin filaments (Tseng et al., 2004); iv) 
tropomyosins which are able to regulate actin dynamics through binding along F-actin and 
interaction with other ABPs or by direct contact of F-actin with different tropomyosin 
isoforms (Gunning et al., 2008; Schevzov et al., 2012); and v) severing proteins (actin 
depolymerizing factor (ADF)/cofilin) that control the rate of actin polymerization and act 
according to their levels of activation in neurons and can stabilize, severe or polymerize 
the actin filament (Andrianantoandro and Pollard, 2006). 
Microtubules (MTs) are the cytoskeletal component that presents the largest 
diameter being composed by α- and β-tubulin heterodimer subunits. Their polarized 
structure is generated by the association of 13 α/β-tubulin dimers resulting in the 
formation of a faster growing (plus) and a slower growing (minus) end (Downing and 
Nogales, 1998). This polarized organization is fundamental in several neuronal processes 
such as morphogenesis, axonal extension and transport of vesicles and proteins (Roy et 
al., 2005). There are several proteins regulating MT dynamics: i) MT plus end tracking 
proteins (adenomatous polyposis coli (APC), end binding 1 and 3 (EB1 and EB3), 
lissencephaly (LIS1), doublecortin (DCX) and cytoplasmic linker-associated proteins 
(CLASPs) that control dynamics, growth directionality and interaction with constituents of 
the cell cortex (Akhmanova and Hoogenraad, 2005; Akhmanova and Steinmetz, 2008; 
Ayala et al., 2007; Barth et al., 2008; Friocourt et al., 2003; Morrison et al., 2002); ii) 
severing proteins that remodel the neuronal MTs during axonal outgrowth (katanin) or 
MTs reconfiguration at branch points (spastin) (Karabay et al., 2004; Roll-Mecak and 
Vale, 2006); iii) destabilizers of MTs that increase the rate of MT depolymerization either 
by tubulin sequestration, action in MT ends or using the energy from ATP hydrolysis 
[stathmin, superior cervical ganglia neural-specific 10 protein (SCG10), SCG10-like 
protein and Kinesin superfamily protein 2A (KIF2A)] (Grenningloh et al., 2004; Hirokawa 
and Noda, 2008); iv) MT stabilizing proteins that are differentially compartmentalized in 
neurons having an impact in MT dynamics being required for axon formation and 
maintenance (microtubule-associated protein 1B (MAP1B) and Tau) (Dehmelt and 
Halpain, 2005). Tubulin has an additional level of regulation and complexity since it can 
undergo several post-translational modifications (PTMs). PTMs include polyamination, 
phosphorylation, acetylation, detyrosination, polyglutamylation and polyglycylation. The α-
tubulin is expressed in a tyrosinated state that has been associated with dynamic MTs, 
whereas detyrosinated and acetylated tubulin are frequently present in stable MTs 
(Magiera and Janke, 2014) However, it is not the PTM modification that confers the 
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stability/instability to tubulin, but the kinetics of the enzymes involved in these alterations. 
In fact, it was shown that acetylation of tubulin occurs by a very slow enzyme which acts 
preferentially in stable tubulin, suggesting that PTMs depend on the state of microtubules 
and do not modulate it dynamics. 
The intermediate filaments (IF) also compose the neuronal cytoskeleton 
participating in the regulation of neuronal differentiation, axonal diameter, outgrowth and 
regeneration (Perrot and Eyer, 2009; Zhu et al., 1997). Two α-helical chains assemble 
forming an antiparallel tetramer, which further connect with seven other tetramers to form 
an IF. Contrary to what occurs in F-actin and MT filaments, the build of IF takes place over 
the whole filament (Fuchs and Cleveland, 1998) (Figure 5 D). 
The growing axon presents a tip denominated growth cone, a structure highly 
enriched in actin (Cajal, 1998). The geometry of the growth cone is divided into three 
domains: the actin rich peripheral zone (P-domain), a MT-rich central zone (C-domain) 
and a MT and actin overlapping transition zone (T-domain). In the central zone of the 
growth cone bundled MTs start to splay out entering in the P-domain. The P-domain is 
enriched in actin protrusions composed by two types of actin organization: filopodia 
(parallel F-actin bundles) and lamellipodia (F-actin branched meshwork) (Figure 5 E). At 
the growth cone the dynamic properties of actin resultant from the combination of F-actin 
treadmilling and retrograde flow provide the growth cone movement in response to 
directional cues (Lowery and Van Vactor, 2009). 
Actin is also enriched in dendrites contributing to their formation and organization 
(Figure 5 A) (Cohen et al., 1985). In dendrites the actin filaments are oriented in a specific 
way with the barbed ends pointing towards the cellular membrane (Matus et al., 1982).  
Actin enriched structures were recently described in the axon shaft forming 
periodic rings of actin linked to spectrin and adducin (Figure 5 B) (Xu et al., 2013). The 
structure of the actin rings is believed to give additional support to the axon. Another novel 
actin structure that was found as component of the axon are the actin trails (Figure 5 C) 
(Ganguly et al., 2015). This structure is composed by dynamic F-actin “hotspots” that 
undergo constant assembly/disassembly. It is thought that this structure provides a 
flexible cytoskeleton to the axon.  
The structure of the axon has to be maintained for long time and distance and the 
bundles of MTs provide support for this particular structure. These bundles are composed 
by discontinued MTs, frequently not attached to the centrosome, and with their plus ends 
towards the tip of the axon and the minus end pointing the cell body (Figure 5 D) (Baas 
and Lin, 2011). Besides the cellular support in the axon shaft, MTs are the highway of the 
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axonal transport. The transport of organelles and vesicles from the cell body towards the 
tip of the axon is named anterograde transport and is carried out by proteins of the kinesin 
family (Hirokawa and Noda, 2008). Retrograde transport is slightly slower than the 
anterograde and is performed in the opposite direction reaching the cell body. The 
molecular motor involved in this type of transport is dynein that, in association with 
dynactin, provides a link between the cargoes and MTs during transport (LaMonte et al., 
2002). This transport is essential to deliver neurotrophic factors from the tip of the axon to 
the cell body (Figure 5 D) (Chao, 2003). 
Some dynamic MTs enter in the dendritic structure presenting, in opposite to what 
is observed in the axon, a mixed polarity. This distinctive feature proposes a functional 
role for the orientation of MTs in axons and dendrites (Gu et al., 2008; Lowery and Van 
Vactor, 2009). 
Figure 5 – Organization of the neuronal cytoskeleton. (A) At the somatodendritic compartment, the 
dendrites are composed by MTs, which are mixed oriented and mostly restricted to the dendritic shaft, with 
some of the MTs protruding into de dendritic spine. Actin filaments form the so-called actin patches and are 
localized inside the dendritic spine. (B) Actin rings are disposed as isolated periodic rings localized in the 
axon and dendrites. (C) Actin trails are dynamic short actin filaments along the axon that undergo constant 
assembly/disassembly cycles and believed to be involved in the delivery of actin to the pre-synaptic 
terminals. (D) Throughout the axon, MTs are displayed in a polarized fashion with the minus end directed 
towards the cell body and the plus end towards the tip of the axon. MTs are the highways in which the 
molecular motors move: kinesin and dynein. Here, IFs form a structural meshwork that encloses MTs. (E) At 
the growing tip of the axon, the growth cone, the cytoskeleton is organized in order to favour growing 
conditions. Actin forms sheet-like structures (lamellipodia) and rod-like structures (filopodia) and at the distal 
part of the axon shaft, MTs protrude into the growth cone running in parallel to F-actin in filopodia. 
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2.2 Signalling regulators of the neuronal cytoskeleton 
 
The neuronal cytoskeleton needs to be under a precise control for correct 
development and maintenance; this control is regulated by several key signalling 
pathways. Proteins of the Rho GTPases family are crucial regulators of the cytoskeletal 
dynamics including cell migration, vesicle trafficking, axonal guidance, cytokinesis and 
endocytosis (Etienne-Manneville and Hall, 2002). Rho GTPases are regulated by guanine 
exchange factors (GEFs), which activate the protein by promoting the exchange of GDP 
for GTP, GTPase-activating proteins (GAPs), which increase the intrinsic GTPase activity, 
inactivating the protein, and guanosine nucleotide dissociation inhibitors (GDIs) that 
maintain GTPases in an inactive state (Jaffe and Hall, 2005). The three canonical Rho 
GTPases are the Ras homologous member A (RhoA), Ras-related C3 botulinum toxin 
substrate 1 (Rac1) and cell division control protein (Cdc42), and they are considered 
major regulators of the neuronal actin cytoskeleton. It has been suggested that RhoA is a 
negative regulator of neuritogenesis and dendrite-axon formation, Rac1 regulates the 
formation of lamellipodia and membrane ruffles, and Cdc42 promotes the formation of 
filipodia and microspikes (Hall, 1998). The small Rho GTPases regulate a number of 
cellular processes in a highly dynamic manner what implies that they have to be tightly 
controlled with main contribution of the spatio-temporal regulation of GEFs and GAPs 
(Pertz, 2010).  
RhoA activation is mediated by the Wnt signalling, inducing the activation of its 
major downstream effector Rho kinase (ROCK), resulting in neurite retraction (Kishida et 
al., 2004; Tsuji et al., 2010). Activated ROCK is able to phosphorylate LIM Kinase 1 
(LIMK1), a kinase that phosphorylates and inactivates ADF and cofilin, mediating the 
RhoA effects in actin turnover and neurite growth (Aizawa et al., 2001; Ng and Luo, 2004). 
Pharmacological agents or ectopic expression of dominant-negative (DN) mutants of 
RhoA/ROCK results in increased neurite formation and occasionally in the formation of 
extra axon-like structures (Arimura and Kaibuchi, 2007; Chuang et al., 2005; Sanchez et 
al., 2008). Formins, that are essential for nucleation and polarization of F-actin, are also 
Rho downstream effectors. The mammalian Diaphanous Formin (mDia) 1 and 2 are the 
most studied, and both retain the capacity to bind to MTs, and this ability is independent of 
their involvement in actin polymerization. The association of mDia with MT interacting 
proteins EB1/APC results in the stabilization of dynamic MT tips during cell migration 
(Wen et al., 2004). 
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Rac1 and Cdc42 have been suggested to act in combination to regulate different 
but complementary functions resulting in neurite outgrowth and growth cone development 
(Hall, 1998). Rac1 is mainly present in the growth cone where it regulates adhesion and 
protrusion activity (Hall, 1998). Activation of Rac1 or its GEF Tiam1 promotes growth cone 
lamellipodial expansion (Leeuwen et al., 1997). Rac1 exerts its functions through the 
activation of two main downstream effectors: the p21-activated kinase (PAK) and Velprolin 
homologue protein (WAVE) (Wiscott-Aldrich syndrome protein (VASP) family). PAK1 
regulates actin dynamics through activation of the LIMK-cofilin pathway implicated in the 
actin turnover and neurite growth (Endo et al., 2003). The loss of WAVE inhibits axon 
extension, suggesting that Rac1-WAVE pathway is necessary for axonal growth 
(Tahirovic et al., 2010). The p35/Cyclin-dependent kinase 5 (Cdk5) is another Rac1 
effector through regulation of PAK1 activity (Nikolic et al., 1998). The complex Cdk5-
RacGTP-PAK1 localizes in the growth cone periphery and impacts in the actin dynamics 
promoting neuronal migration and neurite outgrowth (Rashid et al., 2001). Cdc42 and the 
Par3-Par6-atypical PKC (aPKC) complex have been described as having a role in neurite 
outgrowth and polarization, demonstrated in cultured hippocampal pyramidal cells (Wiggin 
et al., 2005). 
The distinct functions of Rho GTPases imply that they have to be strongly 
regulated. The disruption of this tight regulation has been associated with several 
neurodegenerative diseases such as AD (Ma et al., 2008) and CMT (Chaya et al., 2011). 
In this respect, some inhibitors of RhoA/ROCK pathway emerged as therapeutic 
approaches for those disorders (Gunther et al., 2014; Song et al., 2013; Tonges et al., 
2012). One example is fasudil, a ROCK inhibitor, that when administrated in mouse 
models of AD, leads to a significant ameliorated cognitive impairment and attenuated 
neuronal loss (Song et al., 2013). 
Another known regulator of neuronal cytoskeleton is glycogen synthase kinase 3 
(GSK3) that has two isoforms α and β, and the isoform β is the commonly expressed in 
the nervous system (Hur and Zhou, 2010; Lau et al., 1999). GSK3β acts as a key 
regulator of cytoskeletal elements by controlling several MT related proteins, such as 
MAPs (as MAP1B and Tau), APC, collapsing response mediator proteins 2 and 4 
(CRMP2 and CRMP4), MT plus end-tracking proteins (APC and CLASP2) and MT-
depolymerizing factor stathmin (Seira and Del Rio, 2014). The involvement of GSK3β in 
AD has been largely studied since the kinase catalyses Tau phosphorylation. 
Hyperphosphorylated Tau dissociates from MTs resulting in their disturbance, including 
defects in MT stability and axonal transport (Mokhtar et al., 2013). Another relevant 
FCUP/ICBAS 
DISSECTING THE ROLE OF CYTOSKELETON REMODELLING IN A DROSOPHILA MODEL OF TTR-INDUCED 
NEURODEGENERATION 
 
 52 
substrate of GSK3β is CRMP-2, which binds tubulin heterodimers and promotes MT 
assembly (Fukata et al., 2002). In fact, increased phosphorylation of CRMP-2 has also 
been reported in animal models of AD (Cole et al., 2007). Alterations in the regulation of 
GSK3β can result in several neurodegenerative diseases, and since in disease situations 
it appears upregulated, there has been the development of several GSK3β inhibitors (Lei 
et al., 2011; Martinez et al., 2013). Lithium is one described inhibitor of GSK3β and its 
administration at therapeutic concentrations in cell culture models of AD reduces Tau 
phosphorylation and AD generation (Takahashi et al., 1999). 
 Cdk5 is associated with numerous cellular functions including the regulation of MT 
cytoskeleton in neurons. This role in MTs is closely associated with the interaction of Cdk5 
with MT associated proteins such as MAP1B and Tau (Kawauchi et al., 2005), and with 
other signalling molecules that regulate MT dynamics such as GSK3β (Plattner et al., 
2006; Wen et al., 2008). Besides the known function of Cdk5 in regulation of MTs in 
neurons, more recently it has been described its role in actin organisation in neurons as 
well as other functions namely neuronal adhesion, membrane trafficking, cell cycle exit 
and differentiation (Kawauchi, 2014). The deregulation of Cdk5 is associated with several 
neurodegenerative disorders making this protein a possible target in the research for 
therapeutic approaches. 
Integrins are transmembrane receptors that act as dimers of α/β subunits and bind 
to elements of the ECM transferring information from the extracellular environment to the 
intracellular (Hynes, 2002). Once activated, integrins recruit a number of scaffolding 
proteins forming an intracellular complex. This complex interacts mainly with actin 
cytoskeleton initiating signalling pathways such as the small Rho GTPases pathway 
(Legate et al., 2009). Axonal growth and extension is highly regulated by the ECM-integrin 
communication that occurs during development. Once activated, integrins trigger the 
recruitment of GEFs, as well as the displacement of Rac1 and Cdc42 resulting in the 
formation of new adhesions promoting lamellipodia and filopodia protrusions, respectively 
(Santiago-Medina et al., 2013). The initial phases of development and protrusion require 
the suppression of RhoA activity that can be also achieved by integrin signalling (Bradley 
et al., 2006). The role of integrins in neurodegeneration has also been addressed with 
some evidences of their involvement in synaptic plasticity and inflammatory responses in 
neurodegenerative diseases such as AD and PD (Koenigsknecht and Landreth, 2004; 
Van Gool et al., 1994). This has raised the hypothesis to target integrins in neurological 
disorders (Wu and Reddy, 2012).  
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2.3 Cytoskeleton defects in neurodegenerative disorders 
 
There are strong evidences that support the deregulation of the neuronal 
cytoskeleton in a variety of nervous system diseases (Suchowerska A. H., 2014). 
Cytoskeletal alterations can be promoted by misfolded proteins through activation of 
signalling pathways intimately related with cytoskeleton regulation, or by mutations in 
proteins of the cytoskeleton machinery. 
AD represents the leading disease where cytoskeleton damage has been studied. 
In AD, it has been described a link between the decline in cognition and cytoskeletal 
changes, resulting ultimately in neurodegeneration. One feature of AD is the accumulation 
of hyperphosphorylated Tau in NFTs that promote the disruption of the neuronal 
cytoskeleton (Alonso et al., 1996; Ballatore et al., 2007). AD is also characterized by the 
accumulation of Aβ that has been related to the development of axonal transport defects 
and cofilin-actin rods formation that in turn promote axonal transport impairment and 
synapse disruption (Cichon et al., 2012; Maloney et al., 2005; Minamide et al., 2000). The 
deregulation of Rho GTPases family and the formation of Hirano bodies (inclusions of 
actin and ABPs) were also found in AD (Fulga et al., 2007; Mendoza-Naranjo et al., 2007). 
In other diseases of the central nervous system, several cytoskeletal alterations 
have been reported. Some examples are PD, HD and ALS. Between the defects that have 
been described are: i) impairment of axonal transport (PD, HD and ALS) (Collard et al., 
1995; Ittner et al., 2008; Trushina et al., 2004), ii) formation of actin rods (HD) (Munsie 
and Truant, 2012); iii) alteration in PTMs of tubulin (HD) (Dompierre et al., 2007); 
deregulation of Rho GTPases (PD and HD) (Tourette et al., 2014; Zhou et al., 2011); and 
ABPs mutations or inactivation (ALS and PD) (Bellani et al., 2014; Wu et al., 2012). 
Regarding diseases of the PNS, CMT type 2 is the most prevalent inherited axonal 
neuropathy (Fabrizi et al., 2007). A mouse model of CMT, induced by mutation of the 
small heat shock protein gene (HSPB1), showed decreased levels of α-acetylated tubulin, 
severe axonal transport deficits in the peripheral nerves and deregulation of Rho 
GTPases (d'Ydewalle et al., 2011; Delague et al., 2007).  
In the case of FAP, although being a dying-back axonopathy, what suggests an 
initial disturbance of the axonal cytoskeleton, damage of its components was not 
previously reported. Nevertheless, preliminary data from our laboratory demonstrated that 
dorsal root ganglia neurons (DRG), a relevant cell type for the study of the FAP since TTR 
accumulates closely to DRG, when treated with TTR oligomers present cytoskeleton 
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alterations. These alterations comprised a reduction in growth cone area and disruption of 
the typical morphology of the growth cone which lacks the lamellipodial actin structures 
(Figure 6) (unpublished data).  
   
Figure 6 – Representative images of growth cones of DRG neurons untreated or treated with TTR 
oligomers. (A) Untreated DRG neurons present a growth cone with the normal actin pattern (red) composed 
by filopodia and lamellipodia. The MTs (green) are well organized in bundles that splay out in the central 
domain of the growth cone. (B) DRG neurons treated with TTR oligomers present a completely disorganised 
structure of the growth cone in which actin almost disappears from the structure and is arranged in spikes of 
filopodia without lamellipodia. The MTs structure also appears disrupted forming dystrophic growth cones. 
A B 
βIIII-tubulin 
Phaloidin 
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 3 DROSOPHILA MELANOGASTER AS A MODEL OF HUMAN 
NEURODISORDERS  
 
Drosophila is an insect with an unquestionable importance as a genetic model in 
modern biology and with a central role in our current understanding of the complex biology 
of the higher organisms.  
3.1 Drosophila as a model 
 
Drosophila develops over ten days at 25ºC. In the first 24 hours the embryo 
develops into three subsequent larval stages: L1 and L2, through one day each, followed 
by L3 during about three days. A pupal stage follows over the next four days culminating 
in the eclosion of the adult fly (Chyb, 2013). The structures presented in the adult fly are 
derived from epithelial structures that arise early during embryogenesis and develop 
during larval stages: the imaginal discs. Each imaginal disc gives rise to a specific region 
of the adult fly (Fristrom, 1982).  
Besides a short generation time, Drosophila offers a range of advantages including 
short lifespan, large number of progeny, availability of several techniques to control gene 
expression, and well defined anatomic and phenotypic features (Bilen and Bonini, 2005; 
Matthews et al., 2005). This organism is able to undergo sophisticated manipulations that 
are incomparable with any other multicellular organism, which allows raising several and 
specific questions achieving rapid and reliable answers (Venken and Bellen, 2005). 
Additionally, fly presents a number of external characteristics (types of bristles, eyes, 
wings, between others) that can be used as readouts in genetic screens (Beckingham et 
al., 2005). Another advantage is the size of the fly genome that is approximately 5% of the 
mammalian one but shares conservation with most gene families and pathways in 
mammals. Together, all these advantages make the fly a valuable instrument not only for 
genetic screenings but also for functional analysis of human disease genes (Matthews et 
al., 2005). The success of Drosophila is also due to the free communication, open share 
of fly resources and large-scale production of research tools fomented by fly geneticists 
(Kohler, 1994). 
The fly offers the advantage to perform unbiased genetic screens unrevealing 
gene functions in specific processes (St Johnston, 2002). One method that has been 
increasingly used to study gene function in flies is RNA interference (RNAi). This is a 
process executed by the cells in which double stranded RNA (dsRNA) targets messenger 
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RNA resulting in gene silencing (Fire et al., 1998). Currently there are RNAi libraries to 
silence the majority of the Drosophila genes, which allows a genome-wide screening for 
gene loss-of-function phenotypes. This is particularly interesting in the study of disease 
situations, in which screens enable the discovery of genes that suppress or enhance a 
specific disease phenotype (Beckingham et al., 2005). Moreover, although flies have a 
complex nervous system, their brain presents a minimal barrier which provides the 
opportunity to implement large-scale pharmacological screens (Bilen and Bonini, 2005). 
The expanding fly toolbox has contributed to many aspects of different areas of 
neurobiology and the fly will remain an organism of choice for neuroscientists (Bellen et 
al., 2010). 
 
3.2 The Drosophila visual system  
 
Drosophila nervous system is proportionally complex compared to vertebrates. The 
Drosophila eye starts to develop in mid-embriogenesis, matures over the larval stage as 
the eye imaginal disc, and subsequently undergoes metamorphosis during the pupa stage 
originating the adult structures (Green et al., 1993). The eye-antennal discs develop over 
the first three days of larval stage, initialized by a growth period by cell division, until the 
middle of the third instar stage achieving approximately 10000 cells each eye (Carthew, 
2007). In the early third instar larval stage, cells start to differentiate at the posterior region 
of the disc creating two distinct regions, the proliferative and the differentiated. These two 
regions are separated by a dorsoventral groove in the epithelium called morphogenetic 
furrow that moves along the disc until it reaches the anterior margin about two days later 
(Ready et al., 1976). Differentiation of photoreceptors occurs in a precise manner, with 
cells sending signals to the adjacent cells, in order to develop and organize into an 
ommatidium or unit eye (Tomlinson, 1988). Each ommatidium is composed by eight 
photoreceptor neurons that are divided in three basic classes: R1-R6, R7 and R8 
(Carthew, 2007). Since R8 is the first photoreceptor to be specified and triggers the 
recruitment of the other seven photoreceptors to the ommatidia, its proper specification is 
fundamental (Braitenberg, 1967; Morante et al., 2007). Each array of eight photoreceptors 
sends their axons organized in bundles through a thin tube that connects the eye disc to 
the optic lobe, the optic stalk. In the optic lobe, R1-R6 extend their axons until they reach 
the lamina layer, and R7 and R8 target distinct levels of the medulla layer (Figure 7 A). 
The retinal basal glia (RBG) originated in the optic stalk, travels through the eye disc and 
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is essential for the migration of photoreceptors into the optic lobe (Figure 7 B) (Choi and 
Benzer, 1994). The two layers of glia, namely epithelial glia (eg) and marginal glia (mg), 
signal to stop the growth of photoreceptors R1-R6 in the optic lobe (Figure 7 C) (Poeck et 
al., 2001). 
 
During the first stage of pupa development the eye discs reverse their own 
orientation to re-expose the retina layer to the exterior. This process is accompanied by 
the crude formation of the ommatidia. At the beginning of pupation the cone cells are 
surrounded by a population of interommatidium precursor cells (IPCs) and the primary 
pigment cells starts to enlarge and enclose the cone cells, forming a ring around them and 
preventing their contact with other cells. Once this arrange is established, the remaining 
cells are pushed into the free space between ommatidia. This complex formed by cone 
cells and primary pigment cells start to enlarge forcing the IPCs to a lattice array from 
which arise the secondary and tertiary pigment cells resulting in a functional visual unit 
(Wolff, 1993). In the pupa stage, each photoreceptor projected from the eye disc detaches 
from the bundles of axons of its own ommatidium and associates with the axons that 
capture the same angle of light to project into the lamina layer (Cagan and Ready, 1989). 
The compound eye of an adult fly contains approximately 750 ommatida each one 
composed of 20 cells (Figure 8), which include: i) 8 photoreceptors that appear arranged 
in an asymmetrical way with R1-R6 occupying the outer space and R7 and R8 the inner 
space of the ommatidium; ii) 4 cone cells that produce the lens and the fluid that fills the 
Anterior  
Posterior 
Figure 7 – Schematic representation of photoreceptors projections from the eye disc into the optic 
lobe. (A) An ommatidium containing eight photoreceptors projects trough the optic stalk. The axons R1-R6 
(green) target the lamina layer and R8 (blue) and R7 (red) reach different regions of the medulla layer. (B) 
Glial cells known as retinal basal glia (RGB) are essential in the migration of photoreceptors. The highlighted 
morphogenetic furrow represents the leading edge of the photoreceptors differentiation, since that occurs 
from the posterior to the anterior region of the eye disc. (C) R1-R6 axons (green) stop their growth between 
two layers of glial cells (orange): the epithelial glia (eg) and marginal glia (mg); The axons that target the 
medulla (R8, blue) project through these glia layers and also the medulla glia (me). (Adapted from Tayler and 
Garrity, 2003) 
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pseudocone; iii) 2 bristle cells that make up the mechanosensory system, and iv) 6 
secreting pigment cells divided in primary, secondary and tertiary pigment cells (Wolff, 
1993). The arrangement of these cells forms a trapezoid structure and the rhabdomeres 
embed the photopigments of every photoreceptor. The rhabdomeres extend from each 
photoreceptor into a central domain of the ommatidium and the inner photoreceptors 
contain smaller rhabdomeres occupying the centre of the trapezoid (Zuker, 1996).  
During development, neurons grow in a very stereotyped manner and in the adult fly 
the photoreceptors are arranged in a precise array. Since the internal architecture of the 
fly retina has been particularly well characterized, the smallest modification in cell 
patterning is detected. Furthermore, the intensive study of these processes enabled the 
development of many tools to verify the alterations associated with particular phenotypes. 
Ultimately, because the fly eye is not necessary for its survival and fertility in the 
laboratory, the visual system is an attractive system that has been used to model several 
neurodegenerative diseases. Particularly, the known “rough eye” phenotype resultant from 
a pathologic process is easily studied, allowing screening for genes related to the process 
under study (Bonini and Fortini, 2003; Jeibmann and Paulus, 2009).  
 
Figure 8 – Schematic representation of an ommatidium in the adult fly eye. A longitudinal view (left) and 
three cross-sections (right) at the levels indicated are shown. The cells of the ommatidium are classified in: i) 
photoreceptors, with the six outer photoreceptors shown in shades of blue, and the seventh photoreceptor in 
purple and numbered in the middle cross-section; the eight photoreceptor is shown in green and numbered in 
the lower cross-section; their rhabdomeres are shown in black and is possible to note the asymmetric 
organisation of the rhabdomeres; ii) secreting pigment cells (primary, secondary and tertiary represented in 
shades of red) demonstrated in the upper cross-section; iii) cone cells that secret the lens (L, gray) and fluid-
filled pseudocone (C, gray); and iv) mechanosensory bristles (b, yellow). (Adapted from Brennan and Moses, 
2000) 
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3.3 Drosophila as a model to study cytoskeleton 
 
Fly neurons present several useful features to study cytoskeleton. Most of the 
Drosophila ABPs and MTBPs are highly conserved with their mammalian homologues 
and they are expressed in the nervous system (Sanchez-Soriano et al., 2007). Moreover, 
fly neurons display several similarities with other mammals neuronal systems regarding 
cytoskeletal dynamics. This demonstrates that the basic regulatory mechanisms are well 
conserved (Sanchez-Soriano et al., 2010). Additionally, cytoskeleton regulators usually 
exhibit minimal redundancy in the fly genome. For instance, while is necessary to perform 
a triple KO for some genes in mice, only a single gene needs to be removed in flies 
(Goncalves-Pimentel et al., 2011). Furthermore, several genetic tools as mutant alleles 
are readily available with the possible combination in the same fly within a short time 
(McQuilton et al., 2012). The cytoskeletal machinery is easily studied using genetic 
manipulations of the cytoskeletal regulators in combination with a wide spectrum of 
morphological readouts for axons in vivo, including live imaging of cytoskeletal dynamics 
(Mattie et al., 2010).  
As previously described, during neuronal development one of the more important 
structures formed in the growing axon is the growth cone. Drosophila growth cones 
display several similar features with those of other systems with the typical filopodia and 
lamellipodia structures and MTs entering in the core of the growth cone (Sanchez-Soriano 
et al., 2010). Besides the similar structure, Drosophila neurons present several 
homologues of ABPs (some examples are Arp2/3 and members of the formins family) and 
MT regulators (such as MAP1B, Futsch in Drosophila) (Chesarone and Goode, 2009; 
Hummel et al., 2000). Additionally to the vast homology in the proteins that regulate the 
cytoskeleton dynamics, the signalling regulators of the cytoskeleton are well conserved, 
with flies containing also the three main components of the Rho GTPases family (RhoA, 
Rac1 and Cdc42), one homologue for GSK3β (shaggy) and Cdk5 proteins (Sanchez-
Soriano et al., 2007). 
3.4 Modelling neurodegenerative diseases in Drosophila 
 
Work in flies has proven to increase the knowledge concerning the fundamental 
features of nervous system such as: i) organization and function; ii) integration and 
process of the information; iii) mechanisms regarding molecular and cellular events 
underlying several neurodegenerative diseases; iv) processes that control behaviour and 
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iv) how distinct brain areas are wired (Bellen et al., 2010; Bilen and Bonini, 2005). Taking 
into account the several advantages and tools offered by the Drosophila, the approach to 
model human neurodegenerative diseases in the fly is strongly attractive.  
 There are several models of protein-aggregation diseases using Drosophila, such 
as AD. Although flies do not present conservation in all the components of amyloid 
precursor protein (APP) processing machinery, it has been possible to study several 
aspects of AD with important contributions to increase the knowledge of the disease 
(Driscoll and Gerstbrein, 2003; Kopan and Goate, 2002). It was reported that 
overexpression of WT Presenilin and AD-linked mutant forms triggers programmed cell 
death raising the evidence that this cell loss could be associated with neurodegeneration 
in AD (Ye and Fortini, 1999). Moreover, the expression of some human components of 
APP processing in flies resulted in the production of Aβ40 and Aβ42 fragments leading to 
progressive degeneration of the retina (Greeve et al., 2004). Additionally, the expression 
of human WT Tau and mutated forms of the protein in cholinergic neurons of the fly lead 
to adult-onset progressive neurodegeneration with vacuolization and reduced lifespan 
(Wittmann et al., 2001). Coexpression of human Tau and the fly homologue of GSK3β 
(shaggy) enhanced neurodegeneration and promoted the formation of NFTs (Jackson et 
al., 2002). As a consequence of human Tau expression, flies presented axonal transport 
impairment that was reverted by GSK3β inhibitors (Mudher et al., 2004). 
Other neurodegenerative disorders have been successfully modelled in Drosophila 
such as PD, HD, Spinocerebellar ataxia type 3, spinal muscular atrophy and ALS (Chan et 
al., 2003; Feany and Bender, 2000; Miguel-Aliaga et al., 2000; Pendleton et al., 2002; 
Vonsattel, 2008; Warrick et al., 1998; Watson et al., 2008). 
3.4.1 Drosophila as a model to study FAP  
 
Previous studies attempted to create a successful model for FAP in Drosophila 
(Berg et al., 2009; Pokrzywa et al., 2007; Pokrzywa et al., 2010). Transgenic flies were 
generated with WT and mutant versions of human TTR (TTRL55P, TTRV30M and TTR-A 
(engineered mutant highly destabilized with two substitutions V14N/V16E). All the 
transgenes contained the human secretory signal peptide. As referred above, the 
invertebrates do not express TTR but some of them have TTR-like proteins. Searching for 
TTR sequence homologues in Drosophila we found a protein that exhibits some level of 
homology with TTR (CG30016). It belongs to the TTR/hydroxyisourate hydrolase 
superfamily, however there is no description if the protein is a homotetramer and if exerts 
the same functions as in mammals.  
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The first description of a FAP fly model used the glass multiple reporter (GMR) to 
promote the expression of TTRL55P and TTR-A, in the fly eye (Pokrzywa et al., 2007). In 
this study the formation of aggregates was observed in 30-day-old flies expressing either 
TTRL55P or TTR-A. In TTR-A expressing flies the amyloid nature of these aggregates 
was confirmed by Thioflavin-S positive staining. Both transgenes promoted the 
degeneration of the adult retina and vacuolization of brain structures evaluated by 
immunohistochemistry in cryosections in 30-day-old flies. The wing phenotype was 
evaluated in flies expressing one (heterozygous) or two copies (homozygous) of TTR-A 
transgene and in flies expressing two copies of TTRL55P transgene (homozygous), and 
the results were compared with flies overexpressing two copies of WT TTR. The 
evaluation was performed in the first days of the adult life (0-4 days) and the 
overexpression of WT TTR did not promote an evident phenotype in the wings. Flies 
expressing TTR-A presented a dragged posture of the wings that was more evident in 
heterozygous flies. This result was unexpected but the authors evaluated the state of 
aggregation of the protein and found that the homozygous flies presented a larger 
proportion of high-molecular weight aggregates that were assumed to be less toxic. Flies 
expressing two copies of TTRL55P presented upturned wings, although without high 
frequency of the phenotype. The climbing ability was correlated with the wing phenotype 
as the heterozygous flies expressing TTR-A developed climbing problems while the 
homozygous flies expressing either TTR-A and TTRL55P did not developed flight 
disability. The lifespan was also evaluated. While homozygous flies expressing WT TTR 
did not show an altered lifespan (33 days), expression of TTR-A resulted in reduced 
lifespan in homozygous flies (less 13 days of median survival, compared with wild-type 
flies), being the effect more drastic in heterozygous flies (less 19 days of median survival, 
compared with wild-type flies). Homozygous flies expressing TTRL55P showed a reduced 
median survival of about 12 days when compared to WT flies (Pokrzywa et al., 2007).  
 A second model for TTR-related amyloidosis was generated by the expression of 
either WT TTR or TTRV30M with a HA-tag, in the nervous system (C155-Gal4 promoter) 
and in the eye (GMR-Gal4 promoter) (Berg et al., 2009). It was detected a reduction in the 
survival of flies expressing both transgenes in the nervous system, being mild in flies 
expressing WT TTR (less 4 days of the median survival compared with wild-type flies) and 
more severe in flies expressing TTRV30M (less 8 days of the median survival compared 
with wild-type flies). Although the mutations are different, the reduced lifespan found upon 
expression of mutated TTR is consistent with the work reported previously (Pokrzywa et 
al., 2007), although the mutations are different. In the work reported by Berg et al., (2009) 
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the flies were also tested for their climbing ability and it was found the same tendency as 
the one observed in the lifespan studies. The flies expressing WT TTR showed a mild 
decrease in the capacity to climb, whereas flies expressing TTRV30M showed a marked 
reduction of the ability to climb. Interestingly, in this study, WT TTR expression had an 
effect both in lifespan and climbing activity, which was not observed in the work by 
Pokrzywa et al. (2007). The presence of amyloid deposits in the 20-day-old fly brain was 
confirmed by Congo red positive binding, being moderated in flies expressing WT TTR 
and extensive in TTRV30M expressing flies. The previous work never detected deposits in 
flies expressing WT TTR, neither by western blot or by Thioflavin-S staining. The 
formation of vacuoles was also detected in cryosections of the brain of 20-day-old flies. 
WT TTR expressing flies presented some vacuoles that are absent in control flies, and 
expression of TTRV30M resulted in extensive vacuolization of the brain with large 
vacuoles appearing. The degeneration of the eye was addressed by scanning electron 
microscopy (SEM) in the flies expressing the transgenes under GMR-Gal4 promoter. At 
day 1 of eclosion all the genotypes presented normal eyes, without signs of degeneration. 
At day 25 after eclosion the expression of WT TTR resulted in mild phenotype of the eye, 
and the expression of TTRV30M resulted in collapse and degeneration of the compound 
eye. Mild defects in the retina in WT TTR expressing flies were detected and were not 
reported in the previous work. The difference between the TTR transgenes in the different 
studies is the HA-tag that might affect the stability of the protein and consequently the 
effect in the phenotypes evaluated. 
 A third work studied the expression of WT TTR and the mutated form TTR-A, both 
tagged with FLAG, under GMR promoter (Pokrzywa et al., 2010). This work established a 
correlation between the expression of mutated TTR and formation of intracellular 
aggregates. These were observed in the brain glia and thoracic adipose tissue with 
increase in frequency and size in older flies. The defects described in 14-day-old flies 
expressing TTR-A were majorly the degeneration of the retina and brain vacuolization. 
Flies expressing WT TTR did not show defects in the evaluated structures. A neuronal cell 
culture treated with material extracted from TTR-A expressing flies demonstrated that 
extracts from older flies were less neurotoxic. This corroborates the hypothesis that the 
soluble aggregates are more toxic than the fibrillar ones (Pokrzywa et al., 2010).  
 In the three studies referred above, besides the coherent description of the 
functional phenotypes promoted by mutated TTR and the effect of the protein in the adult 
eye, the molecular mechanisms underlying the observed phenotype were not addressed. 
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Moreover, the defects described promoted by the expression of WT TTR are unclear due 
to the inconsistency between the previous studies. 
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FAP is a disorder characterized by the extracellular deposition of mutated TTR in 
the PNS. Although the intensive research performed in the field, the mechanisms 
underlying the molecular pathways by which TTR causes neurodegeneration are still 
unclear. 
Previous work from our laboratory, using primary cultures of mouse DRG neurons, 
led to the hypothesis that TTR oligomers may promote cytoskeleton remodelling. 
Therefore, we proposed to study this hypothesis in vivo, and search for interactions with 
TTRV30M in a neurodegeneration context, using Drosophila as a model. 
The three main goals of this project were: 
-­‐ Recapitulate and better characterize a previously described Drosophila 
model for FAP; 
-­‐ Study the impact of TTRV30M expression in the cytoskeleton of the retina 
neuroepithelium; 
-­‐ Identify modulators of the TTRV30M-induced phenotype, through a small-
guided genetic screen with major regulators of cytoskeleton dynamics. 
  
  
 
 
 
 
 
 
  
  
  
 
 
 
 
 
 
 
MATERIALS AND METHODS 
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 1 DROSOPHILA MELANOGASTER STRAINS 
 
Flies stocks were maintained on standard Drosophila medium (To 7.5L: 62.5g agar, 
500g corn flour, 62.5g soy flour, 112.5g yeast, 125g malt extract, 210mL molasses, 6.25g 
Nipagin + ethanol, 5mL phosphoric acid and 45.5mL propionic acid, in autoclaved water) 
and crosses were performed on an enriched Drosophila medium (To 7.5L: 56.3g agar, 
375g wheat flour, 750g yeast, 750g sugar, 6.25g Nipagin + ethanol, 37.5mL propionic 
acid, in autoclaved water). The Gal4/UAS system was used to drive expression of 
transgenes in a tissue specific manner. The flies were raised at 25oC and placed to grow 
at 29oC to increase the expression of Gal4 protein. The fly strains used in this study are 
described in Table 1. 
Standard genetic crosses were used to generate the flies analysed in this work and 
a stock harbouring balancers on the 2nd and 3rd chromosomes was used to generate the 
fly lines reported in this work and to insert reporters in the different genetic backgrounds 
(See section1.2). 
 
Table 1 – List of fly strains generated and used in this study with respective genotype and source. 
Construct Genotype Source 
Wild-type w1118 in-house 
cg-gal4 w1118; P{w[+mC]=Cg-GAL4.A}2 Bloomington 
elav-gal4 P{w[+mW.hs]=GawB}elav[C155], 
P{w[+mC]=UAS-mCD8::GFP.L}Ptp4E[LL4], 
P{ry[+t7.2]=hsFLP}1, w[*] 
Bloomington 
GMR-gal4  GMR-gal4; (Hay et al., 1997) 
UAS-Apoliner w*; P{UAS-Apoliner}5 Bloomington 
UAS-Lifeact y1 w*; P{UAS-Lifeact-Ruby}VIE-19A Bloomington 
UAS-mCD4-GFP w1118;PBac{UAS-CD4-tdGFP}VK00033 Bloomington 
UAS-rac1DN y1 w*; P{UAS-Rac1.N17}1 Bloomington 
UAS-rac1CA y1 w*; P{UAS-Rac1.V12}1 Bloomington 
UAS-TTRV30M w1118; P{UAS-TTRV30M-HA} (Berg et al., 2009) 
UAS-TTR w1118; P{UAS-TTRwt} (Pokrzywa et al., 2007) 
Balancers w1118;Sp/CyO;MKRS/TM6b, Tb in-house 
Ey>VitoRNAi w1118;Ey-Gal4,Vitoi/CyO (Marinho et al., 2011) 
GMR>TTR GMR-Gal4;+/+;UAS-TTR/+ This study 
 GMR-Gal4;+/+;UAS-TTR/UAS-TTR  
GMR>TTRV30M GMR-Gal4;+/+;UAS-TTRV30M/+ 
GMR-Gal4;+/+;UAS-TTRV30M/UAS-TTRV30M 
This study 
GMR>GFP GMR-Gal4;+/+;UAS-GFP/UAS-GFP This study 
GMR>Lifeact;TTR GMR-Gal4;UAS-Lifeact/+;UAS-TTR/+ This study 
GMR>Lifeact;TTRV30M GMR-Gal4;UAS-Lifeact/+;UAS-TTRV30M /+ This study 
GMR>Apoliner;TTR GMR-Gal4;UAS-Apoliner/+;UAS-TTR/+ This study 
GMR>Apoliner;TTRV30M GMR-Gal4;UAS-Apoliner/+;UAS-TTRV30M /+ This study 
GMR>TTRV30M,GFP GMR-Gal4;+/+; UAS-TTRV30M /UAS-GFP This study !!Berg,!I.,!Thor,!S.,!Hammarstrom,!P.,!2009.!Modeling!familial!amyloidotic!polyneuropathy!(Transthyretin!V30M)!in!Drosophila!melanogaster.!
Neuro&degenerative.diseases!6,!127H138.!Hay,!B.A.,!Maile,!R.,!Rubin,!G.M.,!1997.!P!element!insertionHdependent!gene!activation!in!the!Drosophila!eye.!Proceedings.of.the.National.Academy.of.
Sciences.of.the.United.States.of.America!94,!5195H5200.!Marinho,!J.,!Casares,!F.,!Pereira,!P.S.,!2011.!The!Drosophila!Nol12!homologue!viriato!is!a!dMyc!target!that!regulates!nucleolar!architecture!and!is!required!for!dMycHstimulated!cell!growth.!Development!138,!349H357.!Pokrzywa,!M.,!Dacklin,!I.,!Hultmark,!D.,!Lundgren,!E.,!2007.!Misfolded!transthyretin!causes!behavioral!changes!in!a!Drosophila!model!for!transthyretinHassociated!amyloidosis.!The.European.journal.of.
neuroscience!26,!913H924.!!
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1.1 The Gal4/UAS system  
The GAL4/UAS system is derived from yeast and is used in Drosophila to direct the 
expression of a gene of interest with spatial and temporal control (Brand and Perrimon, 
1993). The gal4 gene encodes the yeast transcription activator protein GAL4 that binds to 
the Upstream Activation Sequence (UAS) and activates gene expression. Upstream the 
GAL4 sequence is located an enhancer sequence that enables the expression of the Gal4 
protein in a specific tissue/cell type. The UAS sequence is found upstream the target 
gene, and controls its expression (Figure 9). 
 
One of the most used Gal4 promoters is GMR (Hay et al., 1997). It drives the 
expression of the target gene in the photoreceptors and accessory cells of the eye 
posterior to the morphogenetic furrow, from postembryonic stages until 2 weeks after fly 
eclosion. 
 
 2 EXPRESSION OF TTR IN THE FLY VISUAL SYSTEM  
 
The GMR promoter was used to drive the expression of WT (UAS-TTR) and mutant 
versions (UAS-TTRV30M) of human TTR in the fly visual system. The mating scheme of 
the generation of homozygous flies is described in Figure 10.  
 
 
 
Figure 9 – Gal4/UAS system. Transgenic flies expressing the protein Gal4 are crossed with transgenic flies 
carrying the UAS sequence upstream of the gene of interest. The enhancer sequence promotes the 
expression of Gal4 protein and consequently the gene of interest in a specific tissue. (Adapted from 
Jeibmann and Paulus, 2009) 
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 3 WESTERN BLOT 
 
Six fly heads of each genotype, at day 1 after eclosion, were separated from the 
bodies by cutting the neck and the proboscis of the fly. The heads were homogenized in 
20µL of Laemmli Sample Buffer (50mM Tris-HCl pH 6.8, 2% SDS, 100mM β-
mercaptoethanol, 10% glycerol and 0.1% bromophenol blue) and frozen until use. To 
proceed with the denaturation of the tissue, the samples were thawed and heated at 
100oC for 5 minutes and centrifuged at 13000 rpm for 5 minutes.  
Samples (20µL) were run in a 15% SDS-PAGE gel and then transferred to a 
nitrocellulose membrane (0.45µm GE HealthCare). The transfer was performed overnight 
at 4oC, in a wet system in transfer buffer (39mM glycine, 48mM Tris, 20% methanol) at 
25V, with magnetic agitation. The membrane was washed with deionized water, followed 
by a wash with TBS (500mM Tris-HCl, 150mM NaCl) and then with TBS-T (TBS with 
0,05% Tween (Sigma-Aldrich)). Subsequently, the membrane was incubated with blocking 
solution (5% milk (Sigma-Aldrich) in TBS-T) for 1 hour at room temperature. The 
membrane was incubated with primary antibodies (listed in Table 2) in 5% milk in TBS-T 
for 1 hour at RT. The membrane was washed 3 x 10 minutes in TBS-T and then incubated 
with secondary antibodies conjugated with Horseradish-Peroxidase, diluted in 2% milk in 
TBS-T for 1 hour at RT. Immunodetection was performed by chemiluminescence using 
ECL (Bio-Rad) reagent and membranes were exposed to film (GE HealthCare). 
Figure 10 – Matting scheme describing the crosses performed to generate the homozygous flies expressing 
TTR. A similar matting scheme was used to generate homozygous flies expressing GFP.  
GMR− Gal4Y ;++ ;UAS− TTRTM6B,Tb !!!!!!X!!!!!!ww ;++ ;UAS− TTRUAS− TTR!!!GMR− Gal4+ ;++ ;UAS− TTRTM6B,Tb !!!!!!X!!!!!!wY ;++ ;UAS− TTRUAS− TTR!!!
v 
v 
v v 
v 
P:#
F2:#
F1:#
F3:#
F4:#
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 4 EYE PHENOTYPE ASSESSMENT  
 
The heterozygous and homozygous flies expressing WT TTR and TTRV30M were 
evaluated regarding the phenotype in the eye. Since within a population with the same 
genotype different penetrance of the phenotype was observed, it was decided to classify 
the phenotype based on four different categories (Table 2). The images of the eyes were 
acquired in a stereomicroscope Stemi 2000 Zeiss equipped with camera Nikon Digital 
SMZ 1500, with a magnification of 50X. 
 
 
 
 5 LIFESPAN ASSAY 
 
The assays were performed at 25ºC and 29ºC and homozygous flies of the following 
genotypes: wild-type, GMR>GFP, GMR>TTR and GMR>TTRV30M were evaluated. Flies 
were separated in groups of 20 flies per vial, in a total of hundred flies per genotype 
(approximately 50% females and 50% males) and were transferred into fresh vials every 
two days and the dead flies scored. The median survival was plotted as the survival of the 
50% of the flies. 
 
Table 2 – Classification and description of the phenotypes obtained upon TTR expression in the eye. 
No phenotype 
Grade 1 
Grade 2 
Grade 3 
Classification                Phenotype           Description 
Organized eye 
Slight disorganization of the 
eye 
Roughness throughout the eye 
field 
Rough eye 
Ommatidia of different sizes 
Smaller eye 
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 6 CLIMBING ASSAY  
 
Twenty flies of each genotype (wild-type, GMR>GFP, GMR>TTR and 
GMR>TTRV30M) were placed in a vial and changed every second day. To perform the 
climbing assay, the flies were shaken to the bottom of the tube and allowed to climb for 20 
seconds. The number of flies that reach the top of the vial was counted. Three vials for 
each genotype were analysed and every vial was counted three times, at each time point 
(1, 5, 10 and 15 days after eclosion). The results are plotted as mean ± s.e.m. (Standard 
Error of the Mean). 
 7 IMMUNOHISTOCHEMISTRY 
 
Third instar larvae were collected and dissected in PBS (10mM Phosphate, 2.68mM 
KCl, 140mM NaCl). The eye-antenna imaginal disc and the larval brain were collected and 
fixed in 3.7% formaldehyde in PBS during 20 minutes. After fixation the tissues were 
washed in PBS, 3 x 10 minutes, followed by 3 x 10 minutes washes in PBT 0,3% (1X PBS 
+ 0,3% Triton X-100 (Sigma-Aldrich)). Incubation with primary antibodies (Table 2) was 
performed overnight in PBT 0,3% at 4oC with agitation. After wash out with PBT 0,3% 3 x 
10 minutes, incubation with secondary antibodies (Table 2) was performed in PBT 0,1% 
(1X PBS + 0,1% Triton X-100) for 3 hours at room temperature. When required samples 
were incubated with Rhodamine-Phaloidin (Invitrogen) (1:400) that selectively stains F-
actin, in parallel with secondary antibodies. The discs were washed 3 x 10 minutes with 
PBT 0,1% and mounted in 50% glycerol in PBS. 
 
Table 3 - List of the antibodies used in this work with respective host, dilution, application and source.  
!
Antibody Host Dilution Application Source 
Primary     
    Chaoptin (24B10) mouse 1:100 IHC Hybridoma Bank 
    Futsch (22C10) mouse 1:100 IHC Hybridoma Bank 
    HRP Cy5 conjugated goat 1:100 IHC Jackson 
immunoresearch 
    hTTR rabbit 1:500/1:1000 IHC/WB DAKO 
    Repo (8D12) mouse 1:10 IHC Hybridoma Bank 
    Tubulin mouse 1:100 000 WB  
Secondary     
    Anti-mouse Alexa 488 donkey 1:1000 IHC Life technologies 
    Anti-mouse Alexa 568 donkey 1:1000 IHC Life technologies 
    Anti-mouse Alexa 647 donkey 1:1000 IHC Life technologies 
    Anti-rabbit Alexa 488 donkey 1:1000 IHC Life technologies 
    Anti-mouse HRP goat 1:20 000 WB Santa-Cruz 
Biotechnology 
    Anti-rabbit HRP goat 1:3000 WB Santa-Cruz 
Biotechnology 
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 8 IMAGING 
 
Larval tissues were imaged using an inverted laser scanning confocal microscope 
(Leica TCS SP5II). The images were acquired under 40X or 63X objectives. Stacks of 
images of 1.8µM of distance were acquired in each imaginal disc and then the z-stacks of 
interest were projected using Fiji software. 
 9 SCANNING ELECTRON MICROSCOPY (SEM) 
 
Three or four flies were analysed per genotype. Flies, at day 1 after eclosion, were 
collected to an eppenforf tube and frozen. The flies were dehydrated through incubation in 
ethanol series (25%, 50%, 75%, 100%) at room temperature during 24 hours each step. 
The dehydrated flies were incubated two times with hexamethildizilasane (HMDS, Sigma), 
air-dried and mounted in gold sputter coating in SEM stubs. The SEM samples were 
coated with Au/Pd thin film, by sputtering using the SPI Module Sputter Coater equipment.  
The imaging was performed using a High resolution (Schottky) Environmental 
Scanning Electron Microscope with X-ray microanalysis and Electron Backscattered 
Diffraction analysis: Quanta 400 FEG ESEM/EDAX Genesis X4M. The images were 
acquired with 400X and 1000X magnification. 
 10   GENETIC SCREENING 
 
A small guided genetic screen was performed, following the mating scheme in 
Figure 11, in which GMR>TTRV30M homozygous flies were crossed with RNAi lines for 
candidate genes (listed in Table 5). 
 
Figure 11 – Matting scheme describing the crosses performed in the genetic screen. 
GMR− Gal4GMR− Gal4 ;++ ;UAS− TTR!"#$UAS− TTR!"#$ !!!!!!!X!!!!!!!wY ;++ ;UAS− RNAiUAS− RNAi!! !!!!! GMR− Gal4+or!Y ;++ ;UAS− TTR!"#$UAS− RNAi !!
v 
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RNAi transgenes in the second or third chromosome were used. For control, we 
generated flies expressing UAS-TTRV30M transgene and UAS-GFP (GMR>TTRV30M,GFP). 
The phenotype of the progeny was classified as described in table 4. 
 
Table 4 - Classification and description of the phenotypes analysed in the genetic screen. 
Table 5 – List of the RNAi stocks used in this work, with respective genotype and source. For 
simplification, in the following sections RNAi will be referred as i, e.g. aPKCi. 
No phenotype 
Rough eye 
Severe 
Classification                         Phenotype                  Description 
Organized eye 
Disorganization of the retina in 
part or throughout the eye 
Severe roughness of the eye 
Ommatidia of different sizes  
Smaller eye  
 
Construct Genotype Source 
apkc RNAi P{KK100874}VIE-260B VDRC 
cdc42 RNAi P{KK108698}VIE-260B VDRC 
cdk 5 RNAi y1 v1; P{TRiP.JF02374}attP2 Bloomington 
dynein RNAi w1118; P{GD12258}v28053 VDRC 
if RNAi y1 v1; P{TRiP.JF02695}attP2 Bloomington 
kinesin RNAi w1118; P{GD12278}v44337 VDRC 
mew RNAi y1 v1; P{TRiP.JF02694}attP2 Bloomington 
mys RNAi P{KK100518}VIE-260B VDRC 
pp1a RNAi P{KK108922}VIE-260B VDRC 
pp2a RNAi w1118; P{GD17607}v49672 VDRC 
rac1 RNAi y1 v1; P{TRiP.JF02813}attP2 e* Bloomington  
rac2 RNAi w1118; P{GD13964}v28926 VDRC 
rho1 RNAi w*; P{UAS-Rho1.325-
786.dsRNA}2/T(2;3)SM6b-TM6B, 
apRK Tb1 
Bloomington 
rock RNAi P{KK107802}VIE-260B VDRC 
scb RNAi y1 v1; P{TRiP.JF02696}attP2 Bloomington 
trio RNAi y1 v1; P{TRiP.JF02815}attP2 Bloomington 
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 11   STATISTIC ANALYSIS 
 
The statistical analysis was performed with GraphPad Prism software version 6. The 
assays with more than one experiment are represented as mean ± s.e.m. Data 
comparison between groups was performed using One-Way ANOVA Turkey’s Multiple 
Comparisons test or Chi-square (and Fisher’s exact) test. P<0.05 was considered 
statistically significant.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS 
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 1 CHARACTERIZATION OF TTR EXPRESSING FLIES  
 
1.1 Expression of human TTR in the fly eye 
 
In FAP occurs deposition of mutant TTR in the PNS. This results in axonal loss in a 
dying-back type manner that ultimately leads to neuronal death. The mechanisms by 
which TTR triggers neurodegeneration are not completely understood. Despite several 
attempts, the mouse models developed are still inadequate to study the TTR 
neuropathology. Two groups generated previously a Drosophila model for FAP based on 
the ectopic expression of WT and mutant versions of TTR, taking advantage of the 
Gal4/UAS system (Berg et al., 2009; Pokrzywa et al., 2007) (See section 3.4.1 from 
Introduction). 
To analyse the effect of TTR expression, we generated flies expressing TTR using 
the previously described transgenic flies carrying either WT TTR (Pokrzywa et al., 2007) 
or TTRV30M (Berg et al., 2009) and the GMR-Gal4 promoter to induce the expression of 
TTR in photoreceptors and accessory cells of the eye. This promoter offers several 
advantages since the eye follows a specific pattern of development and presents a very 
organized structure in the adult stage, becoming easily detectable any defects that arise in 
such structure. Heterozygous flies, with one copy of the transgene (GMR-Gal4>UAS-
TTR/+), and homozygous flies, carrying 2 copies of the transgene (GMR-Gal4>UAS-
TTR/UAS-TTR) raised at 25ºC and 29ºC, were analysed in this study. 
We started by confirming the expression of TTR in fly heads, at day 1 after fly 
eclosion, through western blot (Figure 12). We used flies carrying two copies of UAS-TTR. 
We observed a band correspondent to TTR in flies expressing both WT TTR and 
TTRV30M, which was absent in GMR-Gal4 control flies. As control, we used recombinant 
TTR to confirm the specificity of the TTR bands. The increased molecular weight of TTR 
band in TTRV30M flies was due to the HA-tag present in this construct. The levels of 
tubulin were used as loading control and they were equivalent between the three samples.  
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Figure 12 – Expression of TTR in the fly eye. Western blot from 
fly heads from GMR-Gal4 control flies, and flies expressing either 
WT TTR or TTRV30M. The weight of the TTRV30M band is 
slightly higher since it carries a HA-tag. Recombinant TTR was 
used as positive control demonstrating the specificity of the bands 
from the TTR expressing flies. The well next to recombinant TTR 
is purposely empty. Tubulin was used as loading control. 
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1.2 Flies expressing human TTR present rough eye phenotype 
 
To address the impact of TTR expression in retina morphology we evaluated the 
phenotype in the eye of flies at day 1 after eclosion. In the wild-type flies the retina 
presented the ommatidia distributed in a precise array throughout the eye field. The 
evaluation of flies expressing one copy of the transgene revealed that either WT TTR or 
TTRV30M expressing flies showed normal eyes when raised at 25ºC, but displayed 
phenotype in the eye when grown at 29ºC (Figure 13 A-D). Flies expressing TTRV30M 
exhibited a bigger area of the eye with phenotype than the WT TTR expressing flies 
(compare Figure 13 C and D). 
Regarding the flies expressing two copies of the transgene, at 25ºC the flies 
expressing WT TTR presented a normal eye (Figure 13 E), while TTRV30M expressing 
flies displayed roughness throughout the eye field (Figure 13 F). With the increment of 
temperature to 29ºC, WT TTR expressing flies developed rough eye phenotype (Figure 13 
G). TTRV30M expressing flies exhibited a more severe phenotype of the eye including 
disorganization of the compound eye and ommatidia fusion with occurrence of blisters 
(Figure 13 H). This evaluation allowed us to conclude that the eye phenotype increases 
with the temperature and gene dosage being always severest in the TTRV30M expressing 
flies. The phenotype of the flies was evaluated every 5 days until day 40 after eclosion but 
we did not observe worsening of the phenotype over time (data not shown). Since the flies 
expressing two copies of TTR demonstrated a severe phenotype we decided to pursue 
with these flies in the following experiments. 
GMR>TTR 
Homozygous 
GMR>TTRV30M 
Heterozygous 
GMR>TTR GMR>TTRV30M 
A 
C 
B 
D 
E 
G 
F 
H 
25
o C
 
29
o C
 
Figure 13- Expression of TTR results in rough eye phenotype. (A-D) Representative images of adult 
eyes from flies expressing either one copy of UAS-TTR (A, C) or one copy of UAS-TTRV30M (B, D) 
grown at 25ºC (A, B) and 29ºC (C, D). (F-I) Representative images of adult eyes from flies expressing 
two copies of UAS-TTR (E, G) and two copies of UAS-TTRV30M (F, H) grown at 25ºC (E, G) and 29ºC 
(F, H). 
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We observed that expression of TTRV30M induced rough eye phenotype. However, 
it was observable that the phenotypes were variable within the population of flies with the 
same genotype. To address the variability of the phenotype we decided to classify the 
phenotype in four categories (Figure 14 A): No phenotype; grade 1, with slight 
disorganization of the ommatidia; grade 2, the eye exhibits rough phenotype in which 
disorganization occurs throughout the eye field; and grade 3, the compound eye appears 
highly disorganized and some ommatidia are bigger and the eye seems smaller. 
Considering this characterization, we evaluated the phenotype of flies expressing 
two copies of WT and mutant TTR raised at 25ºC (Figure 14 B). Wild-type flies did not 
show phenotype in the eye. As a second control we also used flies expressing two copies 
of a UAS-GFP, under the control of GMR-Gal4 (GMR>GFP). These flies showed mostly 
no phenotype in the eye, and about 29% of the flies presented eye phenotype. Of these, 
approximately 10.8% presented grade 1, 86.5% grade 2 and 2.7% grade 3. 73% of WT 
TTR expressing flies showed eyes without phenotype, while approximately 18% of the 
flies displayed the grade 1 and only 8.8% of the flies showed the grade 2 of phenotype; 
we did not observe flies with grade 3. In contrast, more than 50% of the flies expressing 
TTRV30M presented phenotype in the eye. Of these, 48.5% presented grade 1, 38,9% 
showed grade 2 and 12.5% displayed grade 3. The distribution of the grades of phenotype 
was statistically different between the control flies (GMR>GFP) and flies expressing either 
WT or mutant TTR. Moreover, TTRV30M expressing flies presented an aggravated 
phenotype that was statistically different from the WT TTR expressing flies.  
At 29ºC the same pattern of the phenotypes was observed in a severest manner 
(Figure 14 C). At this temperature, wild-type flies did not show phenotype in the eye. The 
control flies (GMR>GFP) presented 71.7% of flies without phenotype, approximately 4.4% 
of the flies presented grade 1 and 23.3% of flies showed grade 2. WT TTR expressing 
flies exhibited 57.6% of the flies without phenotype, about 13.9% of the flies with grade 1, 
21.7% with grade 2 and 6.8% with grade 3. TTRV30M expression triggered eye 
phenotype in more than 80% of the flies. Of these, 25.6% presented grade 1, 59.3% 
showed grade 2 and 14.3% developed grade 3 phenotype. Expression of either WT TTR 
or TTRV30M promoted phenotype in the eye that was statistically different from the 
control flies (GMR>GFP). Furthermore, the expression of TTRV30M triggered a severe 
phenotype in the eye that was statistically different from the WT TTR expressing flies.  
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To further characterize the eye degeneration we performed SEM at day 1 after 
eclosion. Wild-type flies showed intact eyes with the ommatidia arranged in a highly 
organized manner (Figure 15 A). The bristles were equivalently distributed over the eye 
with small exceptions where was detected mislocalization of some bristles and bristle 
duplication (Figure 15 A’ black arrow). The control flies GMR>GFP (Figure 15 B, C) 
displayed slight defects either at 25ºC or 29ºC that included generally loss of 
interommatidia bristles (Figure 15 B’ and C’, black arrowheads). WT TTR expressing flies 
(Figure 15 D, E) showed mild phenotype comprising loss of bristles (Figure 15 D’, black 
arrowheads) and ommatidia of different sizes, at the two temperatures analysed (Figure 
15 D’ and E’, white arrowheads). In TTRV30M expressing flies merge between adjacent 
ommatidia, resulting in bigger ommatidia (Figure 15 F’, open black arrowheads), and loss 
of interommatidia bristles were observed. These defects were aggravated in TTRV30M 
expressing flies grown at 29ºC. Another feature of the TTRV30M expressing flies grown at 
Figure 14 – Eye phenotype evaluation in homozygous flies. (A) Representative images of the eyes with 
the different grades of phenotype: No phenotype, grade 1, grade 2 and grade 3. (B) Distribution of the 
phenotypes observed for the different genotypes analyzed, at 25ºC. (C) Distribution of the phenotypes 
observed for the different genotypes analyzed, at 29ºC. At least 100 flies were analyzed, per genotype. 
Statistical significance determined by Chi-square (and Fisher’s exact) test ****P<0.0001. 
No 
phenotype 
Grade 1 Grade 2 Grade 3 
A 
B C
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29ºC was the presence of holes in the compound eye, which might be the result of bristle 
loss (Figure 15 G’’ white arrowhead), although this defect was not present at 25ºC, or 
collapse of the compound eye as some holes were visible in the middle of the ommatidia 
(Figure 15 G’’ open white arrowhead). Moreover, at 29ºC it was also perceptible the 
reduced size of the eye supporting the evidences of eye collapse and degeneration. 
The expression of both TTR transgenes triggered rough eye phenotype in a gene 
dosage and temperature dependent manner being severest in flies expressing the 
mutated form of TTR, whose defects were dissected in detail by SEM evaluation. 
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Figure 15 - Flies expressing TTRV30M display severe eye phenotype. SEM of the eyes of 1-day-old flies. 
(A, A’) Wild-type flies present normal eyes. Arrows in G’ represent the minor imperfections that occur in a 
wild-type eye as occasional mislocalization of bristles and duplication of bristles (black arrow). (B-C’) Control 
flies (GMR>GFP) grown at 25ºC or 29ºC have normal eyes with small irregularities as the lost of 
interommatidia bristles highlighted with black arrowheads. (D-E’) WT TTR expressing flies grown at 25ºC and 
29ºC present almost normal eyes where the irregularities comprise lost of bristles (D’ black arrowheads) and 
ommatidia of different sizes (D’ and E’ white arrowheads). (F-F’) TTRV30M expressing flies grown at 25ºC 
present fused ommatia resulting in bigger ommatidia (open arrowhead) and loss of bristles. (G-G’’) TTRV30M 
expressing flies grown at 29ºC have smaller eyes, fused ommatidia (G’’ open arrowheads), loss of bristles, 
and small holes can be found on the surface of the retina (G’’ closed and open arrowheads). 
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1.3 Flies expressing a mutant form of TTR have reduced lifespan 
One hallmark of degeneration in flies is reduced lifespan. In this respect, the 
previous works modelling FAP in Drosophila showed reduced lifespan of the flies 
expressing mutant TTR. Therefore we analysed the lifespan of TTR expressing flies. The 
lifespan of flies grown at 25ºC is equivalent between all the genotypes analysed (Figure 
16 A), with the flies surviving up to 80 days. The median survival, given by the day at 
which 50% of the flies are still alive, is similar in all genotypes (Figure 16 A, dashed line). 
At 29ºC, flies from all genotypes displayed a reduced survival when compared to 
flies grown at 25ºC; the longest survival is up to 45 days, for control flies (wild-type and 
GMR>GFP) (Figure 16 B). Flies expressing either WT TTR (Figure 16 B, blue line) or 
TTRV30M (Figure 16 B, red line) displayed a decreased survival of approximately 5 days, 
when compared to control flies (Figure 16 B, grey and green lines). However, the 
expression of mutant TTR led to a decrease in the median survival of 10 days when 
compared to WT TTR expressing flies (Figure 16 B, compare the intersection of the red 
and blue lines with dashed line), indicating that TTRV30M expression at 29ºC has a major 
impact in the survival of flies. 
 
A B 
Figure 16 - Flies expressing TTRV30M exhibit reduced lifespan. (A) Evaluation of the lifespan of flies 
raised at 25ºC of the genotypes: wild-type (gray), GMR>TTR (blue) and GMR>TTR
V30M
 (red). The dashed 
line represents the median survival. (B) Evaluation of the lifespan of flies raised at 29ºC of the genotypes: 
wild-type (gray), GMR>GFP (green), GMR>TTR (blue) and GMR>TTR
V30M
 (red). The dashed line represents 
the median survival. 
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1.4 Expression of TTR induces climbing ability impairment  
The previous published works of the Drosophila models for FAP demonstrated that 
when expressed in the eye or nervous system, TTR is secreted and circulates to the 
adjacent tissues (Berg et al., 2009; Pokrzywa et al., 2007). This suggests that TTR might 
impact in distant sites from that of expression. Therefore, we evaluated the climbing ability 
of WT TTR and TTRV30M expressing flies, as a marker for neurological impairment. The 
flies were tested for their climbing ability during 15 days (Figure 17). This assay measures 
the percentage of flies that are able to climb up to the top of the tube in 20 seconds.  
Around 10% of the wild-type flies and 20% of GMR-Gal4 flies showed climbing 
defects throughout the evaluated period. Approximately 20% of the flies expressing WT 
TTR and TTRV30M showed climbing ability defects that were already present at day 1. 
Similarly, at day 5, 20% of the WT TTR expressing flies had climbing ability defects. The 
percentage of flies with defects in climbing was increased to 33% at day 10, and at day 15 
approximately 65% of the flies presented defects in climbing. At day 15, the climbing 
ability of the WT TTR expressing flies was statistically different from the control ones 
(wild-type and GMR-Gal4). Regarding the TTRV30M expressing flies, at day 5, the 
percentage of flies with climbing defects was around 25%, and at day 10 that percentage 
was drastically increased to 61%. At day 10 the climbing ability of TTRV30M expressing 
flies was statistically different from the WT TTR expressing flies. At day 15, about 80% of 
the flies presented defects in the climbing ability, result that was statistically different from 
the control flies (wild-type and GMR-Gal4). These data showed an impairment of the 
climbing ability in flies expressing both TTR transgenes, suggesting that the TTR 
expressed in the eye is able to circulate and to promote defects distally, such as motor 
impairment. 
1
Figure 17 - Climbing ability is impaired in flies expressing either WT TTR or TTRV30M. The evaluation 
of the climbing ability was performed every 5 days during 15 days after fly eclosion. The genotypes evaluated 
were: wild-type (), GMR>GFP (®), GMR>TTR () and GMR>TTRV30M (¡). A total of 60 flies of each 
genotype were evaluated and the results are plotted as the mean ± s.e.m. Statistical significance determined 
by ONE-WAY ANOVA Turkey’s multiple comparisons test ***p<0.001, ****p<0.0001. 
2
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 2 ANALYSIS OF THE EYE NEUROEPITHELIUM ORGANIZATION 
UPON TTR EXPRESSION 
 
2.1 Expression of TTR in the fly visual system 
 
The promoter used in this work (GMR-Gal4) drives the expression of the target gene 
in the photoreceptors and accessory cells of the prospective eye, that in the larvae stage 
is localized in the eye imaginal disc, post morphogenetic furrow.  
To verify the expression pattern of TTR transgenes we performed an 
immunohistochemistry against human TTR. To evaluate a possible cross reactivity of the 
antibody we performed staining of TTR and Phaloidin (stains F-actin) in GMR-Gal4 larvae 
demonstrating the absence of TTR detection in these larvae (Figure 18 A). 
The evaluation of the expression of GFP under GMR promoter in the eye disc 
(Figure 19 A, yellow dashed line) confirmed its expression in the region posterior to the 
morphogenetic furrow (Figure 19 A, green region), and in the projecting axons in the optic 
lobe. WT TTR and TTRV30M expressing larvae were TTR positive in the posterior region, 
but also in the anterior part of the eye disc (Figure 19 B and 19 C, white dashed line). This 
suggests that TTR was secreted to the adjacent tissues. Was also possible to confirm the 
colocalization of TTR with photoreceptor axons, however we could not conclude if the 
protein is inside or around the axons (Figure 19 C, C’ and D, D’).  
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Figure 18 – Immunohistochemistry of TTR in the neuroepithelium during larvae stage. (A) 
Immunohistochemistry of TTR (green, A’) and staining with Phaloidin (red, A’’) in GMR-Gal4 larvae. (B) 
Higher magnifications of A highlighting the photoreceptor projections in optic lobe. ed – eye disc, os – optic 
stalk, ol – optic lobe. 
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Figure 19 – Expression of TTR in the neuroepithelium during larvae stage. (A) Expression of GFP under 
GMR promoter, which is active in the differentiated cells of the eye that are located post morphogenetic 
furrow. (B-E) Analysis of the TTR expression in the eye disc and optic lobe by immunohistochemistry of TTR 
(green) and actin staining by Phaloidin (red) in WT TTR expressing larvae (B) and TTRV30M expressing 
larvae (D). (C, E) Representation of the magnification of the optic lobe of (B, D), respectively. (B’-E’) TTR 
immunolabeling in gray. (B’’-E’’) Phaloidin staining in gray. Yellow dashed line – eye disc; White dashed line 
– morphogenetic furrow that delimitates the anterior and posterior regions of the eye imaginal disc.  
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2.2 Expression of TTR results in axonal targeting failure 
The expression of WT TTR and TTRV30M under GMR promoter induced defects in 
the adult eye as demonstrated in the previous results. To evaluate whether these defects 
were already present in the larval stage, we performed the staining of Chaoptin, a 
photoreceptor membrane glycoprotein and analysed the organization of the 
photoreceptors and their projections into the optic lobe.  
In control larvae, it was perceptible the elevated organization of the photoreceptor 
axons guidance and target during development (Figure 20 A, A’). The neuroepithelium 
presented photoreceptor projections that were consistently spaced with a characteristic 
expanded morphology targeting properly the lamina (Figure 20 A’, arrowhead) and 
medulla layers (Figure 20 A’, arrow and dashed line). 
 
Figure 20 - TTRV30M induces severe defects in axonal target during larval stage. In order to analyze 
the structure of the photoreceptor neurons during larval stage, we used Chaoptin (24B10). (A, A’) The 
control, wild-type larvae show the typical expanded morphology of the projecting axons reaching the lamina 
(A’, arrowhead) and the medulla layers (A’, arrow). Dashed line in A’ represents the terminal layer of the 
axons in the medulla neuropil. (B, B’) Photoreceptors from WT TTR expressing larvae show an appropriate 
projection pattern into the lamina layer (B’, arrow), although some appear skewed (B’, arrowhead), and do not 
penetrate as well as the controls into the medulla layer (dashed line). (C, C’) TTRV30M expressing larvae 
show critical defects such as the excess of innervation in some areas of the lamina (C’, arrow) when 
compared to others (C’, arrowhead). The same pattern is verified in the medulla layer with some areas highly 
enriched in axons (C’, open arrow), when compared to others (C’, open arrowhead).  
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WT TTR expressing larvae presented defects in neuroepithelium organization. The 
majority of R1-R6 photoreceptor axons targeted the lamina layer properly (Figure 20 B’, 
arrow), however some presented irregularities in guidance, appearing skewed in the 
lamina neuropil (Figure 20 B’, arrowhead). Comparing to control larvae, the targeting into 
the medulla layer was considered incorrect and the typical spreading of the photoreceptor 
axons was not observed (Figure 20 B and B’, dashed line). Expression of TTRV30M also 
induced defects in photoreceptor axonal projections (Figure 20 C, C’). The projecting 
axons reached the lamina neuropil but they were misguided and they failed to reach their 
proper targets. Some regions appeared enriched in axons (Figure 20 C’, arrow) while 
others lack axonal projections (Figure 20 C’, arrowhead). In the medulla layer the same 
problems as the ones found in the lamina layer were detected. The axon bundles failed to 
present an expanded morphology and their distribution was irregular (Figure 20 C’, open 
arrow and open arrowhead). The alterations promoted by TTRV30M were aggravated in 
comparison with the expression of WT TTR. The defects found with Chaoptin suggest that 
TTRV30M influenced the axonal outgrowth and guidance of photoreceptors in the optic 
lobe. In contrast, the staining with Chaoptin proposes that the organization of the 
photoreceptors in the eye disc is normal. 
 
2.3 TTR expression induces axonal microtubules defects 
 
In order to evaluate with detail the axonal defects promoted by TTR and try to 
understand the relationship with cytoskeleton organization we stained the projecting 
axons with Futsch, the homologue of the MAP1B in Drosophila, to visualize the MT 
bundles. Wild-type larvae displayed a highly organized structure in which the 
photoreceptor axons are able to project into the optic lobe and target correctly the lamina 
(Figure 21 A and B, arrows) and medulla layers (Figure 21 A and B, arrowheads). The 
axon bundles appeared equivalent between each other, what is characteristic of the 
elevated organization of this structure. WT TTR expressing larvae presented mild defects. 
The axons in their majority reached the target layers but some of them appeared 
misguided (Figure 21 C and C’, arrow). The bundles of axons did not appear so equivalent 
as the controls, indicating some failure in the arrangement of the axon bundles during 
extension. TTRV30M expressing larvae displayed several defects in targeting. The axons 
reached the lamina layer (Figure 21 E, arrow) but they seemed incapable to extend trough 
the medulla layer (Figure 21 E, arrowhead). Additionally, the bundles were not equivalent 
with some axons coming out the bundles in the wrong direction (Figure 21 E’, arrow). In 
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Figure 21 F we observed misguided axons as they are growing in an opposite direction 
(Figure 21 F, arrow). It was also evident that the axon bundles in the lamina layer 
terminated as blunt ends (Figure 21 F, arrowhead). The analysis of the MT bundles 
suggests that the axonal structure is disrupted in larvae expressing both TTR transgenes, 
being severest in TTRV30M expressing larvae. 
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Figure 21 - Expression of TTR leads to axonal-MT defects. In order to analyze the structure of the axonal 
MTs of photoreceptor neurons in the fly visual system, eye imaginal discs from 3rd instar larvae were stained 
with Futsch (22C10). (A, B) Wild-type larvae present parallel bundles of MTs projecting into the lamina 
(arrow) and medulla (arrowhead) neuropils. (C-D’) WT TTR expressing larvae show the majority of the MT 
axon bundles reaching the different layers properly, but some of them are misguided (C’, arrow) and the 
bundles of axons are not evenly distributed (D’, arrow). (E-F) Expression of TTRV30M triggers several 
defects in the organization of the MT bundles: these are misguided and the bundles are not equivalent (E, 
arrow). The axons reach the lamina layer but they seem incapable to extend trough the medulla layer (E, 
arrowhead). At high magnification is possible to observe some axons coming out of the bundle organization 
(E’, arrow). Another defect detected is that the axons grow in an opposite direction (F, arrow) and fail to 
establish connections with the lamina neurons, and present blunt ends (F, arrowhead). 
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2.4 TTR expressing larvae display altered actin distribution in the 
growth cone 
Previous work developed in our group, using DRG neurons, implies cytoskeleton 
remodelling upon treatment with TTR oligomers (unpublished data). The growth cones of 
the cultured neurons showed mostly alterations in the actin distribution. Therefore we 
analysed the distribution of the actin in the growth cones of photoreceptor axons. 
GMR>TTR flies were crossed with the UAS-Lifeact transgene in order to label the F-actin 
in the growth cone. The control flies, expressing Lifeact (Figure 22 A and A’, B and B’), 
presented actin enrichment in the tip where it appeared well spread suggesting the 
presence of filopodia and lamellipodia, as it is usually observed in a typical growth cone 
(Figure 22 A’ and B’, arrows). It was also evident that the growth cones were equivalent in 
all the axons presenting a star-shaped organization (Figure 22 A’ and B’). WT TTR 
expressing larvae showed in general organized growth cones with well-distributed 
filopodia and lamellipodia (Figure 22 C’ and D’, arrow), although some of the tips 
presented a more compacted pattern of the actin (Figure 22 C’, arrowheads). TTRV30M 
expressing larvae presented an altered distribution of the actin in the growth cones, which 
seemed slightly disrupted and not as equivalently distributed as the controls (Figure 22 E, 
F). Although the growth cones presented filopodia and lamellipodia, some of them 
acquired a compacted structure, without the typical spread pattern, and some filopodia 
emerged out of the tip (Figure 22 E’, arrowhead). Other growth cones appeared too large 
in which the pattern of the actin was disrupted without the star-shaped well established 
(Figure 22 E’, arrowhead). Some larvae with highly disorganized axonal projections 
presented shorter axons in which the distribution of the actin in the tip was disrupted 
(Figure 22 F and F’, arrows). The phenotype observed with Lifeact suggests defects in the 
actin pattern promoted mainly by TTRV30M expression, which is consistent with the 
previous findings in our laboratory. Note that these larvae only carry one copy of the TTR 
transgenes, what could be hiding a stronger effect of the TTRV30M in the actin pattern in 
the growth cone. 
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2.5 Expression of TTR does not affect glial cells  
 
During outgrowth the axons reach the target layers and induce the development of 
the optic ganglia stimulating the proliferation of the neuronal precursors in the lamina. 
Furthermore, photoreceptor axons outgrowth also induces differentiation of the lamina 
glial cells, necessary for proper targeting of the axons (Poeck et al., 2001). Since we 
detected defects in the axonal targeting we decided to evaluate whether the glial cells 
would be affected. For that we stained larvae expressing either WT or mutant TTR with 
Repo to assess the glial cells and HRP to label photoreceptor axons. The analysis of the 
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Figure 22 - Actin organization is disrupted in the growth cones of TTR expressing larvae. Actin 
organization was assessed using the UAS-Lifeact-ruby transgene that binds to F-actin. (A-B) GMR-Gal4 flies 
expressing Lifeact. (A’-B’) Higher magnifications of the optic lobe of (A, B), respectively. Growth cones from 
GMR-Gal4 larvae present a normal actin distribution (A’ and B’, arrows). (C-D) Larvae expressing WT TTR 
and Lifeact. (C’-D’) Higher magnifications of the optic lobe of (C, D), respectively. Growth cones from WT 
TTR expressing larvae present in general a normal actin organization (C’ and D’, arrows) although in some of 
them the actin pattern is not so well spread (C’, arrowheads). (E-F) TTRV30M and Lifeact expressing larvae. 
(E’-F’) Higher magnifications of the optic lobe of (E, F), respectively. Growth cones from TTRV30M 
expressing larvae are more compacted (E’, closed arrowhead) or present a disruption of the typical star-
shaped actin distribution (E’, open arrowheads). Growth cones from altered axon projections loose the 
normal pattern of actin organization (F’, arrows). 
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control GMR-Gal4 demonstrated positive glial cells positioned in the lamina layer (Figure 
23 A, white arrows). Expression of WT TTR or TTRV30M did not seem to modify the glial 
cells during larval stages, as it was possible to detect signal from glial cells around the 
photoreceptors in the lamina layer (Figure 23 B and C, arrows). However, the axons of the 
TTRV30M expressing larvae were highly disorganized influencing the correct analysis of 
that region. Concluding, there seems to be no differences in the levels and position of glial 
cells as a consequence of TTRV30M expression although it would be necessary to 
perform an alternative approach, as count the number of glial cells, or evaluate the 
differentiation of specific glial cells types, to confirm that. 
 
 
2.6 Expression of TTR does not induce caspase activation 
Activation of caspases has been described as one possible cellular event mediated 
by TTR oligomers deposition (Macedo et al., 2007; Sousa et al., 2001b). In order to 
evaluate the activation of cellular death mediated by caspases, we used the Apoliner 
system (Figure 24 A) (Bardet et al., 2008). This construct consists in two fused fluorescent 
proteins: RFP (red) with a membrane sequence signal (mCD8-RFP), and GFP (green) 
with a nuclear sequence signal (NLS-eGFP). In the presence of caspase activity the 
sequence of DIAP1, that is present between the two signals, is efficiently cleaved 
releasing the NLS-eGFP that migrates and accumulates in the nucleus. In the positive 
control for caspase activation (Ey>vito RNAi/Apoliner) (Figure 24 B), the tissue appeared 
mostly magenta (red signal) with green dots in the nucleus demonstrating the cleavage of 
the protein and the migration of the moiety NLS-eGFP to the nucleus (Figure 24 B’, 
arrows). In the negative control GMR>Apoliner, and in WT TTR and TTRV30M expressing 
Wild%type* GMR>TTR# GMR>TTRV30M#
 HRP   Repo A* B* C* HRP   Repo  HRP   Repo 
Figure 23 – Expression of TTR does not affect larvae glial cells. To evaluate the influence of the WT TTR 
and TTRV30M in glial cells we stained 3
rd
 instar larvae with HRP that specifically labels the photoreceptor 
neurons and Repo that stains glial cells. (A) GMR-Gal4 control flies present glial cells normally distributed 
throughout the lamina layer (arrows). (B-C) Larvae expressing either WT TTR (B) or TTRV30M (C) do not 
present defects as the glial cells are correctly surrounding the lamina photoreceptor axons (B and C, arrows). 
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larvae the majority of the signal observed was white, which indicates co-localization of 
both fluorophores, suggesting that caspases are not active (Figure 24 C, D and E). The 
magnifications showed a predominant magenta signal without the presence of green dots 
(Figure 24 C’, D’ and E’). These results suggest that TTR expression does not induce 
caspase activation in larvae.  
 
 
 
 
 
 
Figure 24 - Activation of caspases is not detectable in larvae expressing either WT or mutant TTR. As 
a readout of caspase activity we used the Apoliner construct. The cell bodies of photoreceptor neurons are 
located at the apical region of the eye imaginal disc. This structure was analyzed since this construct signals 
specifically to the membrane and nucleus. (A) Schematic representation of Apoliner that is composed by a 
fusion of an RFP protein with a membrane localization signal (mCD8-RFP) and an eGFP protein fused with a 
nuclear localization signal (nls-eGFP). These two moieties are linked with a sequence of DIAP1 that is 
cleaved in the presence of caspases; the BIR sequence enhances the recognition by caspases. The asterisk 
marks the cleavage site. (B, B’) Caspases are activated in the Ey>vitoRNAi (Marinho et al., 2011) 
background and this was used as positive control. (C-E) GMR-Gal4 control larvae (C) expressing Apoliner, 
and larvae expressing either WT TTR (D) or TTRV30M (E) and Apoliner demonstrated a general white signal 
indicating the colocalization of the green and magenta signals and consequent absence of caspase activity. 
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 3 GENETIC SCREENING: IDENTIFICATION OF MODULATORS OF 
TTRV30M-INDUCED ROUGH EYE 
 
The evaluation of axonal projections in TTRV30M expressing larvae revealed 
alterations in MT bundles and actin organization. These findings suggest an involvement 
of TTRV30M in cytoskeleton remodelling. Therefore, to identify potential TTR-interacting 
molecules in a neurodegenerative context, we performed a small-guided genetic screen 
with proteins involved in cytoskeleton regulation. In this screen we crossed flies 
expressing TTRV30M with readily available RNAi strains for the selected proteins, and 
screened for modifiers of the rough eye phenotype induced by TTRV30M.  
Since the screened flies carry one copy of the UAS-TTRV30M and one copy of the 
UAS-RNAi, we crossed the homozygous flies GMR>TTRV30M with a UAS-GFP strain to 
use as control, thus two copies of UAS transgenes were present in all backgrounds. The 
analysis of the eye phenotype was performed at day 1 after eclosion and distributed in 
three categories (Figure 25 A): No phenotype; Rough eye, when the compound eye 
appeared disorganized in part or throughout the eye; and Severe when there were 
additional defects to the rough eye, as ommatidia of different sizes and smaller eye. The 
evaluation of the control flies expressing TTRV30M and GFP showed that approximately 
55.2% of the flies presented no eye phenotype, 39.4% of the flies showed rough eye and 
5.4% of the flies had severe phenotype (Figure 25 B).  
Besides the evaluation of the adult eye phenotype we also assessed the 
organization of the photoreceptors during larval stages. Flies expressing GFP 
(GMR>GFP) showed a highly organized structure (Figure 25 C) where the photoreceptors 
grew reaching properly the lamina (Figure 25 C’, arrow) and medulla layers (Figure 25 C’, 
arrowhead). In larvae expressing TTRV30M and GFP (Figure 25 D), our control for the 
screen, we found irregularities in the lamina plexus, which appeared disrupted (Figure 25 
D’, arrow) and the axons present defects when targeting into the medulla neuropil (Figure 
25 D’, arrowhead). In the larvae expressing TTRV30M and GFP, the staining of Chaoptin 
showed similar defects (Figure 25 E, F and G). Moreover, it was detected a variability in 
the penetrance of the phenotype in larval stage as some projections showed minor 
defects (Figure 25 E), and others presented mild to severe defects (Figure 25 F and G) 
respectively. 
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  The evaluation with GFP signal and Chaoptin staining demonstrated that the 
expression of one copy of TTRV30M transgene was sufficient to promote defects in the fly 
visual system during larvae development and in the adult eye, what allowed its use as a 
control in the search for modifiers of the TTRV30M-induced phenotype.  
Figure 25 – Characterization of the control flies used in the genetic screen. (A) Representative pictures 
of the phenotype observed in the adult eye and the corresponding categories evaluated in the genetic 
screening: No phenotype, rough eye (flies with a minor or marked disorganization of the compound eye) and 
severe (flies with highly disorganized structure of the compound eye and with bigger ommatidia). (B) 
Distribution of the phenotypes of the control flies of the screen. A total of 4 independent experiments were 
performed resulting in a total of 229 flies evaluated. The results were plotted as mean ± s.e.m. (C, C’) Larvae 
GMR>GFP present a highly ordered structure with photoreceptor axons reaching properly the lamina (arrow) 
and medulla layer (arrowhead). (D, D’) TTRV30M and GFP expressing larvae display several defects as the 
lamina plexus is disrupted (arrows) and the photoreceptor axons fail to penetrate in the medulla neuropil 
(arrowheads). (E-G) TTRV30M and GFP expressing larvae stained for Chaoptin present different penetrance 
of the phenotype including minor (E’), mild (F’) or severe (G’) defects in the photoreceptor axonal projections. 
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3.1 Rho GTPases modulate the phenotype promoted by TTRV30M 
 
Rho GTPases are major regulators of the actin cytoskeleton, whose family 
comprises RhoA, Rac1 and Cdc42 (Gonzalez-Billault et al., 2012). Since we have 
documented alterations of the neuronal cytoskeleton we analysed the involvement of the 
Rho GTPases in the modulation of the phenotype promoted by TTRV30M.  
The silence of RhoA in flies resulted majorly (99%) in flies with rough eye phenotype 
(Figure 26). Silencing of RhoA in TTRV30M expressing flies aggravated the eye 
phenotype. When compared to control flies the number of flies without phenotype was 
reduced (from 55.2% to 48.2%) and a higher percentage of flies with severe phenotype 
was observed (from 5.5% to 21.2%) (Figure 26). This result suggests that RhoA could be 
involved in the modulation of the phenotype induced by TTRV30M although we cannot 
exclude the possibility of cumulative effect of the silencing RhoA and expression of 
TTRV30M.   
 
 
As ROCK is the main downstream effector of RhoA, we went to evaluate the 
involvement of ROCK in the phenotype promoted by TTRV30M. The silencing of ROCK 
under GMR promoter resulted in rough eye phenotype in the majority (68.3%) of the flies 
Figure 26 - RhoA and ROCK modulate the phenotype induced by TTRV30M. Evaluation of the eye 
phenotype of the following flies: GMR>TTRV30M,GFP, GMR>RhoAi, GMR>TTRV30M,RhoAi, GMR>ROCKi and 
GMR>TTRV30M,ROCKi. The phenotype was classified as without phenotype, rough eye and severe. The 
number of flies evaluated with each genotype is indicated in the respective column. Statistical significance 
determined by Chi-square (and Fisher’s exact) test *P<0.05, **P<0.01. 
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with a small percentage of flies without phenotype (31.8%) (Figure 26). The silencing of 
ROCK in flies expressing TTRV30M showed a surprisingly ameliorated phenotype as 
demonstrated by the increased percentage of flies without phenotype (from 55% to 73%) 
and reduced percentage of flies with the rough (from 39% to 26%) and severe (from 5.5% 
to 0.5%) eye phenotypes (Figure 26). This result suggests that the phenotype promoted 
by TTRV30M could be in some extent modulated by RhoA or ROCK but not in the same 
pathway. 
Another protein of the Rho GTPase family is Rac1. Testing the Rac1 RNAi under 
GMR promoter we verified that 90% of the flies did not develop eye phenotype and 
approximately 10% of the flies had a rough eye phenotype (Figure 27). Silencing of Rac1 
in TTRV30M expressing flies led to a significant suppression of the eye phenotype. This 
alteration comprised essentially the ablation of the severe phenotype and reduction in the 
number of flies with rough eye (from 39.4% to 20.2%) (Figure 27). In order to confirm the 
rescue of the phenotype promoted by Rac1 RNAi we analysed flies expressing a Rac1 
dominant negative (DN). The DN form of Rac1 binds GEFs but does not allow its function, 
thus this protein is inactive. Expression of Rac1 DN under GMR promoted rough eye 
phenotype (Figure 27). 
Figure 27 - Rac1 might be involved in the phenotype promoted by TTRV30M. Evaluation of the eye 
phenotype of the following flies: GMR>TTRV30M,GFP, GMR>Rac1i, GMR>TTRV30M,Rac1i, GMR>Rac1DN, 
GMR>TTRV30M,Rac1DN, GMR>TTRV30M,Rac1CA, GMR>TTRV30M,Rac2i and GMR>TTRV30M,Trioi. The 
phenotype was classified as without phenotype, rough eye and severe. The number of flies evaluated in each 
genotype is indicated in the respective column. Statistical significance determined by Chi-square (and 
Fisher’s exact) test  ***P<0.001, ****P<0.0001. 
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The expression of TTRV30M and Rac1 DN showed rescue of the severe phenotype, 
increased number of flies with rough eye (from 39.3% to 51.8%) and decreased number of 
flies without phenotype (from 55.2% to 48.1%) (Figure 27). We also used a Rac1 
constitutively active (CA), which constitutes a protein constitutively active. The expression 
of Rac1 CA under GMR is pupa lethal indicating a deleterious effect of the constitutive 
activation of Rac1. Flies expressing TTRV30M and Rac1 CA showed no eye phenotype. 
This result suggests a beneficial effect of the Rac1 activation in the suppression of the 
phenotype promoted by TTRV30M (Figure 27). We also tested the silencing of Rac2 that 
has equivalent functions to Rac1 in Drosophila. The silencing of Rac2 resulted in the 
suppression of the severe phenotype, decreased percentage of flies with rough eye 
phenotype (from 39.3% to 28.0%) and increased percentage of flies without phenotype 
(from 55.2% to 71.9%) (Figure 27). 
In Drosophila, Trio is a Rac GEF that activates Rac1 and Rac2 and this activation is 
essential during axon growth and guidance (Hakeda-Suzuki et al., 2002). We detected 
that the expression of TTRV30M and depletion of Trio resulted in rescue of the phenotype 
with an increased number of flies without phenotype (from 55.2% to 72.9%), decreased 
percentage of flies with rough eye (from 39.3% to 27.1%) and the severe phenotype 
disappeared (Figure 28). As this result was consistent with the effect of silencing either 
Rac1 or Rac2 in the phenotype promoted by TTRV30M we assumed that the pathway 
Trio/Rac1/2 might be in some extent involved in the modulation of the phenotype 
promoted by TTRV30M. 
To further characterize the rescue of the phenotype with Rac1 RNAi we performed 
SEM (Figure 28 A, B). Control flies expressing TTRV30M and GFP (Figure 28 A) 
presented deregulated compound eye with some bigger ommatidia appearing and there 
was loss of several bristles. This phenotype was totally recovered in the flies expressing 
TTRV30M and Rac1 RNAi (Figure 28 B). We next analysed whether the disorganization 
of the photoreceptor projections observed during larval stages could be rescued with the 
expression of Rac1 RNAi (Figure 28 C, D). Larvae expressing TTRV30M and GFP 
stained for Chaoptin presented the defects previously described including defects in the 
lamina plexus and failure to project properly into the medulla layer (Figure 28 C). The 
expression of Rac1 RNAi in TTRV30M expressing larvae rescued this phenotype, and 
photoreceptor axons were properly projected into the lamina and medulla layers  (Figure 
28 D). 
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Cdc42 is the other major component of the Rho GTPase family. In the actin 
cytoskeleton Rac1 and Cdc42 play distinct but complementary functions. The expression 
of Cdc42 RNAi under GMR promoter resulted majorly in rough eye phenotype (76.6%) 
and in a small percentage (23.4%) of flies without phenotype (Figure 29). The silencing of 
Cdc42 in TTRV30M expressing flies rescued the phenotype, as the severe phenotype 
almost disappeared (from 5.5% to 1.1%), the rough eye phenotype is reduced in less 10% 
of the flies (from 39.3% to 29.46%) and the number of flies without phenotype was 
increased (from 55.2% to 69.5%) (Figure 29). This proposes a possible role of Cdc42 in 
the modulation of the phenotype triggered by TTRV30M.  
 
 
Figure 28 - Rac1 appears to modulate the phenotype promoted by TTRV30M. (A, B) SEM of control flies 
expressing TTRV30M (A) and flies expressing TTRV30M and Rac1 RNAi (B). (C, D) Staining with Chaoptin of  
larvae expressing TTRV30M and GFP (C) and larvae expressing TTRV30M and Rac1 RNAi (D). 
C chaoptin C’ 
A
GMR>TTRV30M,GFP 
A’ B
D
GMR>TTRV30M,Rac1i 
D’ chaoptin  
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Figure 29 - The TTRV30M-induced 
phenotype seems to be modulated by 
Cdc42. Evaluation of the eye phenotype of 
the following flies: GMR>TTRV30M,GFP, 
GMR>Cdc42i and GMR>TTRV30M,Cdc42i. 
The phenotype was classified as without 
phenotype, rough eye and severe. The 
number of flies evaluated with each 
genotype is indicated in the respective 
column. Statistical significance determined 
by Chi-square (and Fisher’s exact) test 
****P<0.0001. 
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The results described above point to a major involvement of the Rho GTPase family 
in the phenotype triggered by TTRV30M. 
 
3.2 Regulators of the cytoskeleton pathways are associated with 
TTRV30M-induced phenotype 
 
Besides Rho GTPases, the neuronal cytoskeleton is also regulated by other 
molecules such as Cdk5. Cdk5 is involved in the actin dynamics and MT stability and 
transport (Kawauchi, 2014). The silencing of Cdk5 (Figure 30) in TTRV30M expressing 
flies promoted the suppression of the severe phenotype, decreased the percentage of 
flies with rough eye (from 39.3% to 21.2%) and increased the number of flies without 
phenotype (from 55.2% to 78.8%). However, these results were not statistically different 
from the control flies because of the small number of flies evaluated and the variability 
observed between experiments. 
To maintain the axonal integrity, the intracellular transport of vesicles and organelles 
is crucial. One of the hallmarks of neurodegenerative diseases is the disruption of the 
axonal transport. To evaluate whether the axonal transport is affected upon expression of 
TTRV30M we evaluated the silencing of kinesin and dynein, the two molecular motors 
involved in axonal transport. The downregulation of kinesin, that participates in the 
anterograde transport, in TTRV30M expressing flies resulted in suppression of severe 
phenotype, reduced percentage of flies with rough eye (from 39.3% to 34.3%) and an 
increase in 10% of the flies that showed no eye phenotype (from 55.2% to 65.7%) (Figure 
30). Although the modification of the phenotypes is quite evident, the distribution was not 
statistically different from the control what can be due to the low number of flies evaluated. 
The silencing of dynein, which is involved in the retrograde transport, caused an alteration 
in the phenotype promoted by TTRV30M. The modifications included the suppression of 
the severe phenotype, increased number of flies with rough eye (from 39.3% to 53.3%) 
and decreased percentage of flies without phenotype (From 55.2% to 46.6%) (Figure 30). 
There is a strong link between aPKC and regulation of the neuronal cytoskeleton 
mainly through the interaction with the small Rho GTPases. aPKC RNAi improved the 
phenotype of the TTRV30M expressing flies. This was evidenced through the suppression 
of severe phenotype, decline of 15% in flies with rough eye (from 39.3% to 24.6%) and 
increase of 20% in flies without phenotype (from 55.2% to 75.4%) (Figure 30). 
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In neurodegenerative disorders, namely AD, has been documented the deregulation 
of the levels of the protein phosphatases namely PP1 and PP2A (Tian and Wang, 2002). 
In order to study if these proteins are to some extent involved in the phenotype promoted 
by TTRV30M, we analysed the effect of PP1A and PP2A RNAi. The silencing of PP1A 
resulted in the total rescue of the phenotype promoted by TTRV30M as all the flies 
presented no eye phenotype. Expression of TTRV30M and PP2A RNAi promoted a 
significant rescue of the phenotype as the flies did not present eyes with severe 
phenotype, there were fewer flies with rough eye phenotype (From 39.3% to 34.3%), and 
the number of flies without phenotype was increased (From 55.2% to 65.7%) (Figure 30). 
Since we verified a significant rescue of the phenotype with PP1A RNAi we further 
characterized this recue by SEM and immunohistochemistry. The defects presented in the 
adult eye of flies expressing TTRV30M and GFP (Figure 31 A) were referred above and 
these were completely rescued in the flies expressing TTRV30M and PP1A RNAi (Figure 
31 B). 
Figure 30 – Molecules associated with the regulation of cytoskeleton dynamics influence the 
phenotype promoted by TTRV30M. Evaluation of the phenotype of the following flies: GMR>TTRV30M,GFP, 
GMR>TTRV30M,Cdk5i, GMR>TTRV30M,Kinesini, GMR>TTRV30M,Dyneini, GMR>aPKCi;TTRV30M, 
GMR>PP1Ai;TTRV30M and GMR>TTRV30M,PP2Ai. The phenotype was classified as without phenotype, rough 
eye and severe. The number of flies evaluated with each genotype is indicated in the respective column. 
Statistical significance determined by Chi-square (and Fisher’s exact) test ****P<0.0001, **P<0.001 
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The results of immunohistochemistry with Chaoptin showed the large rescue of the 
defects presented in control larva (Figure 31 C) as the larvae expressing TTRV30M and 
RNAi presented highly organized photoreceptors forming the characteristic expanded 
morphology of the projections (Figure 31 D). 
 
3.3 Integrins are implicated in the phenotype promoted by TTRV30M 
 
Integrins are fundamentally involved in cell adhesion and in transmission of the 
extracellular signals to the intracellular milieu. Furthermore, integrins mediate the 
regulation of cytoskeleton dynamics mostly via Rho GTPases (Legate et al., 2009). As 
integrins are transmembrane proteins and TTR deposits are extracellular, we 
hypothesized whether integrins could mediate the effect of TTR in neurons. As integrins 
act as α/β dimers, we silenced each subunit separately. The silencing of the αPS1 subunit 
under GMR promoter resulted predominantly in rough eye phenotype (77.5%). The 
silencing of αPS1 in TTRV30M expressing flies induced suppression of the severe 
phenotype, reduced percentage of flies with rough eye (from 39.3% to 16.5%) and 
increased number of flies without phenotype (from 55.2% to 83.5%) (Figure 32). The 
down regulation of the subunit αPS2 or βPS in flies expressing TTRV30M did not modify 
significantly the phenotype triggered by TTRV30M expression (Figure 32). Flies 
Figure 31 – PP1A is involved in the phenotype promoted by TTRV30M.  (A, B) SEM of control flies 
expressing TTRV30M and GFP (A) and flies expressing TTRV30M and PP1A RNAi (B). (C, D) Staining of 
Chaoptin in the larvae expressing TTRV30M and GFP (C) and larvae expressing TTRV30M and PP1A 
RNAi (D).  
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expressing TTRV30M and αPS3 RNAi presented alterations in the eye phenotype. These 
differences comprised a decreased number of flies without phenotype (from 55.2% to 
44.7%, increased number of flies with rough eye (from 39.3% to 55.3%) and abolished the 
severe phenotype (Figure 32). This was an intricate result since a suppression or 
enhancement of the phenotype is nor clear. 
 Since the result with αPS1 RNAi was the most consistent and reverted significantly 
the phenotype promoted by TTRV30M expression, we performed SEM and 
immunohistochemistry with those flies (Figure 33). By SEM it was noticeable the 
impressive suppression of the phenotype in the flies expressing αPS1 RNAi (Figure 33 B) 
when compared to the control flies (Figure 33 A). The same was confirmed by 
immunohistochemistry where the expression of αPS1 RNAi recovered the organization of 
the photoreceptor axons projections (Figure 33 C, D). 
Figure 32 – The phenotype triggered by TTRV30M might be modified by integrins. Evaluation of the 
phenotype in GMR>TTRV30M,GFP, GMR>αPS1i, GMR>TTRV30M,αPS1i, GMR>TTRV30M,αPS2i, 
GMR>TTRV30M,αPS3i and GMR>βPSi;TTRV30M. The phenotype was classified as without phenotype, rough 
eye and severe. The number of flies evaluated with each genotype is indicated in the respective column. 
Statistical significance determined by chi-square (and Fisher’s exact) test ****P<0.0001, **P<0.001. 
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Figure 33 - αPS1 integrin subunit modulates the phenotype promoted by TTRV30M. (A-B) SEM of 
control flies, expressing TTRV30M and GFP (A) and of flies expressing TTRV30M and αPS1 RNAi (B). (C-D) 
Staining of Chaoptin in larvae expressing TTRV30M and GFP (C) and larvae expressing TTRV30M and 
αPS1 RNAi (D).  
B
D
GMR>TTRV30M,αPS1i 
B’ 
D’ chaop&n(C chaoptin C’ 
A
GMR>TTRV30M,GFP 
A’ 
FCUP/ICBAS 
DISSECTING THE ROLE OF CYTOSKELETON REMODELLING IN A DROSOPHILA MODEL OF TTR-INDUCED 
NEURODEGENERATION 
 
 108 
 4 GAL4 PROMOTERS 
4.1 Unveiling the drawbacks of the GMR promoter 
 
The GMR promoter has been intensively used to model several diseases including 
neurodegenerative diseases. Given the extremely conserved pattern of formation and 
organisation of the Drosophila compound eye, this model system offers several 
advantages since the smallest alteration is likely to be detected either during development 
or in the adult eye. 
In this work we started by generating flies expressing one copy of the TTR 
transgene, as described previously (Berg et al., 2009). To increase the penetrance of the 
phenotype we placed the flies to grow at 29ºC. As control we used GMR-Gal4 flies grown 
at 29ºC; however, these flies presented a severe eye phenotype. When we quantified the 
percentage of flies according to the previous established grades we detected that 
approximately 35% of the GMR-Gal4 flies had eye phenotype (Figure 34 A). Some flies 
showed grade 3 phenotype (4%) that was majorly present in female flies (33% of females 
with grade 3). As this problem might arise from the accumulation of Gal4 protein in the 
eye resulting in the toxic effect, we generated flies expressing two copies of UAS-GFP 
under GMR promoter (GMR>GFP) to use as control in our experiments. These flies also 
presented phenotype (28%), however the grade 3 was almost absent (1%). The females 
had a substantial recovery of the phenotype when compared to the females without 
expression of GFP (females with phenotype: from 75% to 34%). Moreover, the distribution 
of the phenotypes in females was equivalent to the whole population (males + females) 
(Figure 34 A). We also detected reduced lifespan of the GMR-Gal4 flies that was totally 
reverted to wild-type levels in the flies expressing two copies of GFP (Figure 34 B). 
Although the survival was affected in GMR-Gal4 flies, the climbing ability was not affected 
(see Figure 17). The analysis of the neuroepithelium organization showed a few defects in 
GMR-Gal4 homozygous. The eye disc appeared disrupted with the ommatidia disordered 
(Figure 34 D, arrow), the optic stalk was larger (Figure 34 D, arrowhead), and the 
projecting axons were highly misguided (Figure 34 D, open arrowhead), when compared 
to wild-type larvae (Figure 34 C). 
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4.2 Use of other promoters in the study of neurodegeneration 
induced by TTR transgenes 
 
In order to evaluate the effects of the expression of TTR under other promoters we 
tested the ELAV (embryonic lethal abnormal visual system) and Cg promoters. The Elav-
Gal4 promoter drives the expression of the target gene specifically in the nervous system 
and Cg-Gal4 promotes the expression of the transgenes in the fat body. 
We crossed Elav-Gal4 flies with both TTR transgenes (WT and mutant) generating 
flies expressing one copy of WT TTR and TTRV30M in the photoreceptors. The flies were 
grown at 29ºC and the phenotype in the eye was evaluated at day 1 after eclosion (Figure 
35). The results showed that the flies expressing either WT TTR or TTRV30M did not 
present phenotype in the eye when compared to wild-type flies (Figure 35).  
B
chaoptin C D
GMR-Gal4 Wild-type 
A
Figure 34 - Excess of Gal4 protein expressed under GMR promoter induces defects in the eye. (A) 
Distribution of the phenotypes in: wild-type flies; GMR-Gal4 flies grown at 29ºC and the respective distribution 
of the phenotypes in the females; flies expressing two copies of GFP and grown at 29ºC and the respective 
distribution in the females. (B) Survival assay at 29ºC of the wild-type flies (gray), flies GMR-Gal4 (red), and 
flies expressing two copies of GFP (green). (C, D) 3rd instar larvae fly visual system of wild-type (C) and 
GMR-Gal4 grown at 29ºC (D), stained with Chaoptin. The defects of GMR-Gal4 larvae include 
disorganization of the photoreceptors in the eye disc (D, arrow), a larger optic stalk (D, closed arrowhead), 
and defects in the axonal projections (D, open arrowhead).  
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In humans, TTR is expressed in the liver, the source of protein to the plasma. In 
flies, the fat body is the metabolic tissue with similar functions to the adipose tissue and 
liver. As TTR is secreted upon expression and pathologically accumulates in the nervous 
system, we evaluated the photoreceptor projections after TTR expression in the fat body. 
We evaluated the fly visual system in 3rd instar larval stage of development by the staining 
with Futsch. The wild-type larvae showed normal organization of the photoreceptor axons 
with the characteristic expanded morphology (Figure 36 A, A’). The WT TTR expressing 
larvae presented	   the normal projections	   from the optic stalk into the optic lobe reaching 
the lamina layer. However, some bundles of axons were not completely equivalent 
between each other suggesting a slightly deregulation of the MTs (Figure 36 B, B’, 
arrows). TTRV30M expressing larvae showed defects in axonal projections; these were 
not evenly spaced (Figure 36 C, C’, arrow) and some of them were misguided (Figure 36 
C’, arrowhead). This result suggests that TTR is effectively secreted upon expression and 
circulates to the adjacent tissues inducing defects in the photoreceptors neurons. 
  
Figure 35 – Flies expressing TTR under ELAV promoter do not present eye phenotype. Flies 
expressing one copy of either WT TTR or TTRV30M under Elav promoter, that drives the expression of the 
target gene in the photoreceptors, were grown at 29ºC. The eye phenotype was evaluated at day 1 after 
eclosion and classified in four categories: No phenotype, grade 1, grade 2 and grade 3. 
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Figure 36 – Expression of TTR in the fat body induces defects in the photoreceptor axons. Effects of the 
expression of TTR under a promoter of the fat body (Cg) were evaluated by staining of Futsch in the fly visual 
system at 3rd instar larval stage of development. (A, A’) Wild-type larvae present the normal and characteristic 
photoreceptor projections into the optic lobe. (B, B’) WT TTR expressing larvae show mild defects in the 
axonal projections and they do not spread evenly in the lamina layer (C’, arrows). (C-C’) TTRV30M expressing 
larvae results in several defects as the axonal bundles are not consistently spaced in the medulla layer (D’, 
arrow), and some axons appear misguided (D’, arrowheads).   
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 1 THE DROSOPHILA MODEL OF FAP 
 
FAP is a fatal disorder characterized by the deposition of mutant TTR mainly in the 
PNS resulting in neurodegeneration (Andrade, 1952; Costa et al., 1978). Despite the 
intensive research that has been carried out, the precise mechanisms underlying TTR-
induce neurodegeneration are largely unknown. TTR deposition in the PNS causes axonal 
loss in a dying-back type manner culminating in neuronal death (Said et al., 1984).  
In several neurodegenerative diseases cytoskeleton alterations have been 
described in the course of the disease and associates with the neurodegenerative process 
(Suchowerska A. H., 2014). In FAP, although the mechanisms of axonal loss might 
suggest an initial disturbance of the distal cytoskeleton upon TTR disposition, the study of 
cytoskeleton alterations was not previously addressed. Previous results from our 
laboratory, with primary cultures of DRG neurons, demonstrated that treatment of these 
neurons with TTR oligomers resulted in a marked reduction of the growth cone area, 
disruption of the typical morphology of the growth cone and lack of the lamellipodial actin 
structure, indicating an alteration in the actin cytoskeleton (unpublished data). Based on 
the hypothesis that TTR oligomers impact on cytoskeleton remodelling, we aimed to 
analyse the role of TTR in the neuronal cytoskeleton in vivo using Drosophila as a model. 
Moreover, taking advantage of the model we also performed a genetic screen with 
cytoskeleton regulators as candidates in order to identify possible modulators of the TTR-
induced neurodegeneration.  
The analysis of the eye phenotype in the flies expressing either WT or mutant TTR 
allowed us to conclude that the phenotype promoted by TTR is gene dosage and 
temperature dependent being always severest in flies expressing TTRV30M. Although we 
have followed the flies expressing one copy of TTR transgenes until day 40, we did not 
observe eye phenotype in flies grown at 25ºC. This is contradictory with the previous 
work, where eye phenotype was described at 25 days after eclosion, in flies grown at 
25ºC and expressing only one copy of the same TTRV30M transgene (Berg et al., 2009). 
In our hands, the expression of one copy of WT TTR did not result in eye phenotype, at 
25ºC, which is consistent with the previous published work, which failed to detect 
phenotype in flies expressing the same WT TTR transgene (Pokrzywa et al., 2007). 
However, it would be important to analyse the internal organisation of the adult eye in the 
heterozygous flies to confirm the absence of defects in the old flies. 
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In order to promote eye phenotype the flies were placed to grow at 29ºC and flies 
expressing two copies of the TTR transgenes were generated. Using these approaches, 
we were able to detect eye phenotype at day 1 after eclosion. This result might suggest 
that the expression of low levels of TTR transgenes does not contribute to the 
development of adult eye phenotype, and expression of high levels of protein are 
necessary to induce defects. Moreover, flies expressing two copies of the TTR transgenes 
displayed an eye phenotype with different penetrance, what was initially unexpected. This 
might result from variable levels of protein expressed or due to the different state of 
protein aggregation between flies. In this respect, one of the previous works demonstrated 
that expression of either TTR-A or TTRL55P in the visual system led to protein 
aggregation over time (Pokrzywa et al., 2007). Also, in another study, 20-day-old flies 
expressing one copy of TTRV30M, presented Congo red positive amyloid in the brain 
(Berg et al., 2009). In the present work it would be important to evaluate the aggregation 
status of TTR. 
The expression of two copies of WT TTR also promoted eye phenotype, although 
significantly different from the flies expressing TTRV30M. TTR protein presents a 
structure highly enriched in β-sheets, what increases its predisposition to accumulate 
(Blake et al., 1978), as verified in humans by the accumulation of WT TTR in the heart in 
late stages of life (Westermark et al., 1990). This could explain the mild phenotype 
observed in flies expressing WT TTR. To further confirm that we should test for the 
aggregation potential of the protein in our flies. This is still a conflicting issue since 
concerning WT TTR expressing flies, in the work by Berg et al. (2009) the existence of 
amyloid deposits was demonstrated by Congo red binding, while in Pokrzywa et al. (2007) 
they failed to observe Thioflavine-S staining. 
A strong reduction in the lifespan was also a feature observed in the flies expressing 
TTRV30M, which from day 20 after eclosion presented a drastically reduced survival. Our 
results are in agreement with previous reports where the overexpression of mutated forms 
of TTR induced reduced survival (Berg et al., 2009; Pokrzywa et al., 2007). Additionally, 
this is consistent with the findings in other neurodegenerative diseases modelled in 
Drosophila. 
The evaluation of the climbing ability demonstrated a reduced capacity to climb in 
flies expressing WT TTR that, as discussed before, could be the result of some 
accumulation of TTR in locations distant from the eye. Importantly, the study in which this 
TTR transgene was generated did not report climbing defects in the flies expressing the 
WT TTR protein (Pokrzywa et al., 2007). TTRV30M expressing flies presented a markedly 
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reduced climbing ability that was already evident at day 10. This result correlates with the 
previous findings (Berg et al., 2009; Pokrzywa et al., 2007) and suggests the impact and 
accumulation of TTR on distant sites, from the one of expression, and in the progression 
of the disease. Concerning this result, the evaluation of the integrity of other neurons, 
such as motorneurons, would provide additional evidences regarding the effects of TTR 
distally. Comparing with the survival curve, the locomotor impairment was detected before 
the decrease in the survival suggesting an initial deleterious effect of TTRV30M, which 
posteriorly affects the lifespan. 
One of the previous described models reported that the expression of TTRL55P and 
the engineered mutant TTR-A resulted in mild degeneration of the adult retina and 
vacuolization of the brain structures (Pokrzywa et al., 2007). However, these defects were 
not further investigated, and the molecular events underlying these deficits remained 
unclear. Since we detected eye degeneration promoted by expression of WT TTR and 
TTRV30M, we aimed to look to the neuroepithelium organization at different 
developmental stages, to evaluate the progression of the defects. For this, we evaluated 
the eye imaginal discs from 3rd instar larvae, since if defects are observed these would 
reflect the initial defects induced by TTR accumulation. To elucidate the defects caused 
by TTR overexpression in the cytoskeleton, we stained the MT associated protein Futsch 
and the photoreceptor membrane glycoprotein Chaoptin. The expression of WT TTR 
resulted in mild defects in the neuroepithelium organization while larvae expressing 
TTRV30M showed abnormal fascicles of axons and targeting defects. The evaluation of 
the actin distribution with Lifeact in the growth cones demonstrated that the expression of 
TTRV30M resulted in the disturbance of the typical star-shaped structure, resulting in 
morphologically different growth cones. 
Although this model might not be considered a bona fide model of FAP, since TTR 
is expressed in neurons, we were able to identify axonal defects that may lead to the 
degeneration observed. Moreover, our data indicates that TTRV30M impacts in neuronal 
cytoskeleton remodelling in vivo, in agreement with the findings previously reported in our 
group. This suggests that TTRV30M may be inducing in Drosophila neurons the same 
cytoskeleton defects that might occur in pathological conditions, recapitulating the 
disease. 
Previous studies proposed that Schwann cells are able to express TTR, what might 
be involved in the maintenance of the microenvironment of the PNS and nerve 
regeneration (Murakami et al., 2008). Moreover, mutated TTR deposition occurs in the 
peripheral nerves in close contact with Schwann cells. However, it was described that 
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they are not affected during disease progression since the ratio between the axon 
diameter and myelin thickness is maintained. In accordance with that, in our work we 
confirmed the presence of glial cells around the axons in larvae expressing both TTR 
transgenes. 
As described in the literature, caspase activation has been associated with the 
molecular mechanisms triggered by TTR oligomers (Macedo et al., 2007). In this work we 
failed to detect caspase activation upon expression of WT TTR or TTRV30M, during 3rd 
instar larvae stage. This evidences the lack of caspase activation during the larval stages, 
however we do not know if caspases are activated during posterior stages of 
development. Furthermore, caspases are activated by small TTR aggregates (Saraiva et 
al., 2012) and we did not test for the protein aggregation status of TTR in our flies.  
Over the work we detected that the driver used, GMR, raised some problems 
regarding the eye phenotype and shorter lifespan, which were supressed with the 
generation of homozygous flies expressing GFP. It was reported previously that 
homozygous GMR-Ga4 flies present a rough eye phenotype that when evaluated by SEM 
is mainly composed by disrupted ommatidia arrays and ommatidia of irregular size 
(Kramer and Staveley, 2003). This phenotype was suggested to be promoted by the 
excess of the Gal4 protein that is enhanced at 29ºC, aggravating the phenotype. 
Activation of caspase activity was also described (Kramer and Staveley, 2003). Although 
we have detected the majority of the defects described, in our work GMR-Gal4 larvae 
expressing the Apoliner transgene did not show caspase activation. Despite the defects 
encountered through our work, this promoter continues to be a valuable tool in the use of 
Drosophila as a model, even to model FAP, and with the appropriate controls is possible 
to infer reliable conclusions. 
In parallel with our work we hypothesized the use of others promoters and we tested 
a promoter restricted for photoreceptors (ELAV) and a fat body promoter (Cg). The 
overexpression of TTR under Elav promoter did not result in adult eye phenotype, what 
can be the result of the use of one copy of the promoter and transgene. This might be 
overcome by the generation of flies carrying 2 copies as was did with GMR flies. Cg is a 
strong promoter in the fat body and since TTR is expressed and secreted we were able to 
detect some problems in the axonal projections of the photoreceptor neurons. This 
confirmed the effect of TTR transgenes in other tissues besides the ones of expression, 
which is enhanced with the expression of TTRV30M. Concluding, the expression of TTR 
in the fat body might be a useful approach to posteriorly model FAP in flies.  
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In summary, the expression of TTR under GMR promoter led to the development of 
adult eye phenotype, photoreceptor axons defects, climb disability and reduced lifespan 
that was always more severe with the expression of TTRV30M. 
 2 NOVEL INTERACTORS OF TTR WITH POTENTIAL RELEVANCE IN 
DISEASE 
 
Genetic screens in Drosophila have made important contributions to understand the 
mechanisms associated with the neurodegenerative diseases such as AD (Blard et al., 
2007; Cao et al., 2008; Shulman and Feany, 2003). As the expression of TTRV30M 
promoted rough eye phenotype, we performed a small-scale genetic screen with 
candidate genes encoding for proteins with functions associated with cytoskeleton 
remodelling. We identified mainly suppressors of the phenotype promoted by TTRV30M 
and a single enhancer. 
The preliminary data from our laboratory demonstrated cytoskeleton remodelling of 
DRG neurons treated with TTR oligomers, which was predominantly evident in the 
organization of the actin cytoskeleton. Since the Rho GTPase family is one of the major 
regulators of the actin cytoskeleton, it was of our main interest to test their involvement in 
the phenotype triggered by TTRV30M expression. During development and neuronal 
migration RhoA regulates negatively neuritogenesis (Hall, 1998). Additionally, some 
contradictory results have been published demonstrating that RhoA DN induced 
decreased axon growth in hippocampal neurons (Ahnert-Hilger et al., 2004). Our results 
showed that the silencing of RhoA enhanced the phenotype promoted by TTRV30M. This 
is inconsistent with the role of RhoA during development, although we hypothesized the 
possible cumulative effect of the phenotype promoted by TTRV30M overexpression and 
the silencing of RhoA. 
The major downstream effector of RhoA is ROCK, and the activation of this pathway 
results in a negative regulation of growth cone motility. Our results showed that the 
downregulation of ROCK in flies is in some extent deleterious to the eye. The silencing of 
ROCK in TTRV30M expressing flies supressed the eye phenotype. This suggests a 
positive effect of silencing ROCK pathway, suggesting that it might be upregulated in 
TTRV30M expressing flies. 
Rac 1 has been described to have a role in the formation of lamellipodia, and Cdc42 
is involved in the formation of filopodia. It was described that the ablation of Rac1 either in 
mouse and rat cell cultures and in Drosophila mushroom body neurons promotes defects 
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in axon growth, guidance, branching, pathfinding and neuronal migration (Chen et al., 
2007; Ng et al., 2002; Tahirovic et al., 2010). In contrast, previous reports describing 
expression of Rac1 CA in mouse cortical neurons showed to lead to a decrease in the 
longest neurite and an increase in the proportion of collapsed growth cones in DRG 
neurons (Jin and Strittmatter, 1997; Kubo et al., 2002; Vastrik et al., 1999). Moreover, 
expression of Rac1 DN promoted neurite outgrowth in DRG cells (Fournier et al., 2003). 
Our results showed that the expression of Rac1 RNAi under GMR is not sufficient to 
cause deleterious effects in the fly eye. In contrast, expression of Rac1 DN under GMR 
promoter resulted in the majority of the flies with defects in the eye supporting the 
essential activation of Rac1. Expression of the constitutively active form of Rac1 under 
GMR is pupa lethal. This corroborates the fundamental regulation of the Rac1 protein 
activation/inactivation during development. Regarding the flies expressing TTRV30M, the 
silencing of Rac1 or Cdc42 suppressed the phenotype induced by TTRV30M, which is 
inconsistent with the described functions of both proteins during development. In contrast, 
the expression of TTRV30M and Rac1 DN maintained to some extent the phenotype 
promoted by TTRV30M while the expression of TTRV30M and Rac1 CA completely 
rescued the phenotype, demonstrating a positive impact of the Rac1 activity that might be 
impaired in TTRV30M-induced neurodegeneration. Our results for the silencing of Rac2 
and Trio in the TTRV30M expressing flies confirmed the rescue of the phenotype obtained 
by Rac1 RNAi although further evidences should be addressed to confirm the 
contradictory results with Rac1 RNAi and Rac1 CA. Rho GTPase regulate a plethora of 
signalling pathways. Considering our results and the fact that Rho GTPase proteins are 
regulated by an inactive/active state, it is of major importance to study the function of such 
proteins trough the pharmacological inhibition or by the CA and DN forms of the proteins. 
Another strategy that would be useful is the use of biochemical pull down assays to 
measure the activation state of these Rho GTPases in a context of TTRV30M-induced 
neurodegeneration, as well as evaluate the levels of activation of their downstream 
effectors. 
Although the results from the Rho GTPases downregulation were in some extent not 
conclusive, we consider that there are sufficient evidences of the cytoskeleton 
involvement in the TTRV30M-induced neurodegeneration whose dynamics is majorly 
regulated by Rho GTPases family. This was also corroborated by the modulation of the 
phenotype of TTRV30M expressing flies by aPKC and integrins that are also involved in 
the Rho GTPases signalling pathways and actin cytoskeleton remodelling. 
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Integrins are molecules involved in the cell-ECM and cell-cell adhesion. The 
interaction of integrins with their ligands (eg. laminin) mediates cell migration, proliferation 
and neurite extension (Eva and Fawcett, 2014). Upon activation, integrins signal to the 
downstream effectors, which include the small GTPases, participating in the remodelling 
of the actin cytoskeleton (Legate et al., 2009). A previous work demonstrated that MT 
regulation can also occur downstream of integrins (Lei et al., 2012). Our results with the 
αPS1 subunit are consistent with Rac1 RNAi although, once again are inconsistent with 
the physiological functions of these proteins. Surprisingly, the silencing of the βPS subunit 
did not result in the suppression of the phenotype what would be expected as integrins act 
as α/β dimers and in the absence of αPS1 there were a significant suppression of the 
phenotype. One explanation might be that in the absence of the β subunit the signalling 
from the three αPS becomes compromised aggravating the phenotype of the flies. 
Regarding the modulation of other proteins that participate in the cytoskeleton 
remodelling we tested the protein phosphatases PP1A and PP2A. We detected mainly the 
involvement of the PP1A in the rescue of the phenotype promoted by TTRV30M but 
without testing hypothetical effectors it is difficult to identify the pathway by which this 
improvement occurred. Additionally, we tested Cdk5 that is one of the major regulators of 
the MT cytoskeleton and it was perceptible a slight improvement of the phenotype but 
since the experiments were variable this difference was not statistic and further 
experiments might clarify this result. It would be interesting to study the influence of 
GSK3β in the phenotype promoted by TTRV30M, as it is another major regulator of the 
MT cytoskeleton.  
Some studies have reported the disruption of the axonal transport as an hallmark of 
neurodegenerative diseases (Millecamps and Julien, 2013). We tested the molecular 
motors that promote the transport along the axon but we did not detected alterations of 
the phenotype promoted by TTRV30M with Kinesin RNAi. With Dynein RNAi we detected 
an alteration of the phenotype that might indicate some deregulation of the axonal 
transport. 
 During the genetic screen we did not assess the eye phenotype promoted by the 
expression of all RNAi lines under GMR promoter. This is an approach implemented 
frequently before starting the genetic screen in order to discard the RNAi strains that 
cause rough eye phenotype on their own, dissipating in this manner possible cumulative 
phenotypes. 
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In conclusion, the genetic screening allowed us to confirm the involvement of the 
cytoskeleton regulators as potential mediators of the phenotype induced by TTRV30M 
with high relevance of the Rho GTPase proteins. 
 3 THE FLY AS A USEFUL MODEL FOR THE STUDY OF FAP 
 
In this study, we explored the defects triggered by the expression of TTR transgenes 
in the eye elucidating the value of the Drosophila model for study in vivo the mechanisms 
associated with TTR-induced neurodegeneration. The TTRV30M flies present some 
common features with the other fly models of neurodegenerative diseases as reduced 
lifespan, impaired motor performance, and rough eye phenotype. Additionally, this work 
has revealed important features of the cytoskeleton remodelling in the TTRV30M-induced 
phenotype, which we can hypothesise to be the same defects induced in a disease 
context. Nevertheless, part of the phenotype in the larvae could result from developmental 
defects promoted by TTR, what is not observed in humans and mouse models since the 
nervous system is already developed when the illness settles. To overcome this issue we 
intend to use the Gal80ts system and evaluate the defects in the retina at the adult stage. 
In the present work, the genetic screen performed allowed us to expose candidate 
proteins for the modulation of the phenotype promoted by TTRV30M. Future work should 
include the validation of these candidates in mouse DRG neurons in order to confirm the 
involvement of these proteins in the phenotype previously assessed with TTR oligomers. 
In summary, our work confirmed cytoskeleton defects in TTRV30M-induced 
neurodegeneration and revealed potential molecules underlying this effect what might 
have relevance not only in FAP pathogenesis but also in the identification of novel 
therapeutic approaches. 
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